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Abstract 
KCC2  is  an  important  K+-Cl- cotransporter that along with Na+-K+-2Cl- 
cotransporter, NKCC1 is largely responsible for the regulation of intracellular chloride 
concentration in neurons which determines whether the ionotropic GABAergic/glycinergic 
responses are depolarizing or hyperpolarizing. There are spatiotemporal differences in the 
intracellular chloride concentration in individual neurons which are attributable to a 
differential temporal and spatial activation of cation chloride cotransport mediated by KCC2 
and NKCC1. Post-translational modulation is a fundamental cellular mechanism for such 
spatiotemporal regulation of protein activity. This thesis deals with the work that has been 
ongoing in our laboratory to understand the mechanisms of post-translational regulation of 
KCC2 cotransport function. 
In Study I, we have demonstrated a fast post-translational increase in KCC2 
cotransport function in neonatal rat hippocampus after a single seizure episode. This increase 
of functional KCC2 was caused by an increment in the surface expression of KCC2. Study II 
deals with the establishment of a modified protease cleavage method for quantitative analysis 
of surface expression of proteins using a cold-adapted trypsin. This can serve as a fast and 
reliable procedure and can be easily applied to brain slice preparations as well as cell culture 
systems. In study II, we have also shown that KCC2 has a low surface expression in the rat 
hippocampus but a very fast turn-over rate of the plasmalemmal pool. Not surprisingly, 
modifications in the turn-over rate of the surface pool can be employed as a mechanism to 
regulate the surface expression of KCC2 and consequently its function. Study III deals with 
another post-translational strategy to regulate KCC2 function in the rat hippocampus under 
pathophysiological conditions. While the KCC2 protein is quite stable in the rat hippocampus 
and has a slow turn-over rate under basal conditions, epileptiform activity and excitotoxicity 
can induce a rapid calpain-mediated cleavage of KCC2 with a consequent loss of its 
cotransport function.            
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1. Review of the literature 
1.1  Introduction 
Establishment and maintenance of intra- and extracellular ionic homeostasis is 
essential for normal physiological function of the cell and its appropriate responses to 
intracellular and extracellular perturbations. Cellular ionic regulation in neurons relies on 
maintenance of gradients of ionic concentrations across the cell membrane through a properly 
concerted and coordinated activity of a large number of membrane proteins and receptors 
(ion transporters and channels) that mediate selective ion fluxes across the membrane. 
Regulation of chloride homeostasis is critical for several cellular processes like cell volume 
regulation, cell cycle control, trans-epithelial salt transport, fluid secretion, pH maintenance 
and inter-neuronal communication (Blaesse et al. 2009, Friauf et al. 2011, Russell 2000). 
Although Na+-dependent and Na+-independent Cl-/HCO3- exchangers (Galanopoulou 2008b, 
Kaila 1994, Payne et al. 2003) and Cl- channels like ClC2 (Ben-Ari et al. 2007, Ratte and 
Prescott 2011, Smith et al. 1995) have also been suggested to contribute to chloride 
homeostasis in neurons, cation chloride cotransporters (CCCs) (particularly K+-Cl- 
cotransporter isoform 2 (KCC2) and Na+-K+-2Cl- cotransporter isoform 1 (NKCC1) are 
generally considered major players controlling electrochemical chloride gradient in neurons 
(Blaesse et al. 2009, Friauf et al. 2011, Mercado et al. 2004, Payne et al. 2003).  
CCCs are secondary active transporters (i.e., they use energy from ATP 
indirectly in the form of K+ and Na+ gradients generated by Na+-K+ ATPase) that mediate the 
coupled transport of chloride and cations (K+ and/or Na+) down a combined chemical 
potential difference (see section 1.2.2 and Fig.1). Nine genes in the CCC gene family (solute 
carrier family 12; SLC12) have been identified: one Na+-Cl- cotransporter (NCC), two Na+-
K+-2Cl- cotransporters  (NKCC1  and  2),  four  K+-Cl- cotransporters (KCC1-4) (Mount and 
Gamba 2001), a cation chloride cotransporter isoform 9 (CCC9) that transports polyamines 
and amino acids (Daigle et al. 2009) and a structurally related protein, cation chloride 
cotransporter interacting protein (CIP) that can modulate the cotransport activity of KCCs 
and NKCCs (Caron et al. 2000, Wenz et al. 2009). The predicted protein structure of the CCC 
proteins reveals a membrane topology with a central hydrophobic core containing 12 ?-
helical transmembrane domains (TM), a hydrophilic amino (N-) and a larger carboxy (C-) 
terminal domain, both of which are cytoplasmic (Mercado et al. 2004, 2006, Williams et al. 
1999).  
One of the CCCs, the neuron-specific K+-Cl- cotransporter, KCC2, encoded by 
the SLC12A5 gene, was identified as an essential protein for maintaining a low intracellular 
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chloride concentration ([Cl-]i) in adult neurons because of its ability to extrude Cl- against its 
electrochemical gradient using the outward K+ concentration gradient created by the Na+-K+ 
ATP  pump  (DeFazio  et  al.  2000,  Rivera  et  al.  1999).  Hence,  it  plays  a  crucial  role  in  
controlling the strength of synaptic inhibition mediated by ?-amino-butyric acid type-A 
(GABAAR) and glycine (GlyR) receptors, both of which are ligand-gated Cl- channels (see 
section 1.2.2.1).  Several studies have been targeted to elucidate the molecular and cellular 
mechanisms controlling KCC2 function. Moreover, recent studies affirming a structural role 
of KCC2 in spine formation and maintenance (see section 1.2.2.4), only add to the relevance 
of studies on functional regulation of this key molecule in the brain. Similar to all proteins, 
gene transcription and protein translation set the first level of regulation of KCC2 function. 
However, the role of post-translational regulation of KCC2 function has also become an 
interesting area of research in recent years. These post-translational mechanisms which 
include protein maturation and intracellular protein trafficking, 
phosphorylation/dephosphorylation, protein complex assembly and protein degradation, 
provide a basis for reversible regulation of KCC2 function that allows fast plasticity of inter-
neuronal communication.  
 
1.2  Physiology of KCC2  
As previously stated, the CCC family includes four KCC isoforms, namely 
KCC1-4. KCC2 has certain unique features that aids its physiological role as a Cl- efflux 
pathway in mature neurons allowing the maintenance of a low [Cl-]i required for efficient 
inhibitory neurotransmission in neural circuits. KCC2 is unique among the KCCs in its 
exclusive expression in central neurons (see sections 1.2.1 and 1.3.1). Importantly, while 
KCC2 unlike other KCCs exhibits little or no swelling-induced activation, it is constitutively 
active under isotonic conditions (see section 1.4.3). This has been attributed to presence of a 
unique 15-amino acid fragment (called the isotonic domain) within the C-terminus of KCC2 
(Mercado et al. 2006), although Bergeron et al. (2006) have proposed that the mere presence 
of this fragment is not sufficient but rather depends on the context in the whole C-terminal 
sequence. Unlike other KCCs, KCC2 operates near equilibrium close to the physiological 
levels of [Cl-]i and [K+]o and hence has been suggested to be capable of mediating both exit 
and entry pathways for Cl- (see section 1.2.2.3). A recent study has also outlined differences 
in the requirement of cysteine residues in the large extracellular loop for the cotransport 
function of KCC2 and KCC4 (Hartmann et al. 2010). However, the exact role of the cysteine 
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residues in modulating KCC2 function or its surface expression and contribution to its unique 
physiological role in neurons is yet to be identified.       
 
1.2.1  Expression  
KCC2  is  abundantly  expressed  in  most  neurons  in  the  mature  central  nervous  
system (CNS), but shows negligible expression in non-neuronal cells like glia and astrocytes, 
undifferentiated neuronal progenitors and peripheral neurons (Hubner et al. 2001, Li H. et al. 
2002, Payne et al. 1996, Rivera et al. 1999, Song et al. 2002, Williams et al. 1999). 
Interestingly, SLC12A5 gene that encodes KCC2 has been shown to transcribe into two 
mRNA transcripts by usage of an alternative promoter and the first exon, resulting in the 
expression of two different isoforms, KCC2a and KCC2b (Uvarov et al. 2007, 2009). 
Although both isoforms are capable of comparable furosemide-sensitive cotransport activity 
in heterologous expression systems, expression of KCC2a isoform shows only a modest 
change during postnatal development, while KCC2b expression increases during 
development and dominates that of KCC2a in the mature neuronal systems.   
In the adult CNS, KCC2 protein is expressed in the spinal cord, brainstem, 
cerebellum, cortex, and hippocampus (Payne et al. 1996). In the embryonic CNS, KCC2 
expression increases differentially in different regions in the brain with time in a more or less 
caudal-rostral direction which corresponds to the neuronal maturation pattern in the brain 
(Ikeda M. et al. 2003, Li H. et al. 2002, Rivera et al. 1999, Stein et al. 2004, Wang C. et al. 
2002). Hence, KCC2 expression is only detectable in differentiated neurons and not in 
neuronal precursors (Li H. et al. 2002). Also, there are reports of differences in the expression 
levels of KCC2 in neurons of the same anatomical regions depending upon their maturation 
level (Li H. et al. 2002, Rivera et al. 1999, Takayama and Inoue 2010). Animals that are 
prenatally more developed than rodents have a higher level of KCC2 already at birth (Hyde et 
al. 2011, Rivera et al. 1999, Vanhatalo et al. 2005). Not surprisingly then, KCC2 has come to 
be regarded as a marker for neuronal maturation (Li H. et al. 2002, Mikawa et al. 2002, 
Rivera et al. 1999, 2005, Shimizu-Okabe et al. 2002, Stein et al. 2004).  
At the cellular level, KCC2 protein shows a punctate expression at the plasma 
membrane of both the soma and dendrites of hippocampal and cortical neurons but not in the 
axon terminals (Bartho et al. 2004, Gulacsi et al. 2003, Gulyas et al. 2001, Hubner et al. 
2001, Szabadics et al. 2006, Takayama and Inoue 2006, Zhu L. et al. 2005). KCC2 is also 
highly expressed in the dendritic spines (Gulyas et al. 2001, Zhu L. et al. 2005) where it is 
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known to play a structural role in establishment and maintenance of spines (see section 
1.2.2.4). 
 
1.2.2  Function  
The main physiological role of CCCs is regulation of [Cl-]i. However, under 
normal physiological conditions, the direction of net chloride transport is different for the 
NKCCs  and  the  KCCs  in  most  cells.  This  is  based  upon  the  requirement  of  CCCs  (as  
secondary active transporters) for the electrochemical gradient of the principle ion (Na+ or 
K+) as the energy source for chloride transport (see Fig.1). While NCCs and NKCCs typically 
transport chloride into the cell, KCCs typically extrude chloride (Kaila 1994). As transport of 
chloride into and out of the cell is obligatorily accompanied by the influx and efflux of water, 
respectively, the CCCs can aid in the regulation of cell volume (MacAulay et al. 2004).  
Since KCC2 cotransport is electroneutral i.e. carries K+ and Cl- in  a  
stoichiometric ratio of 1:1 in the same direction (Kaila 1994, Payne 1997, Williams and 
Payne 2004), it has no direct effect on the membrane potential (Farrant and Kaila 2007, 
Mercado et al. 2004). In absence of any voltage-dependence of its cotransporter activity, 
KCC2 function is also independent of membrane potential but depends only on the sum of 
chemical potential differences for K+ and Cl- which is set by the outwardly directed K+ 
chemical potential maintained by Na+-K+ ATPase (Farrant and Kaila 2007, Kaila 1994, 
Payne 1997). Under normal physiological conditions, KCC2 is near its point of 
thermodynamic flux reversal point (for equilibrium conditions, see Fig.1), hence it can 
mediate either net ion efflux or net ion influx depending on small changes in [Cl-]i and [K+]o, 
(see section 1.2.2.3). In addition to K+, cations like Rb+, NH4+ and  Cs+ can all serve as 
substrates for KCC2 cotransport and while kinetics of transport of Rb+ and NH4+ are similar 
to K+, Cs+ transport rate is excessively reduced (Williams and Payne 2004). This can serve as 
a basis for measurement of KCC2 cotransport function by measuring radioactive Rb+ fluxes 
(Payne 1997).    
In  neurons,  regulation  of  [Cl-]i by CCCs is essential for determining the 
properties of inhibitory neurotransmission which is mediated by Cl- permeant ion channels 
GABAAR and GlyR, although both of these channels are also known to be permeable to 
HCO3- (see sections 1.2.2.1 and 1.2.2.3). KCC2 and NKCC1 are the main CCCs involved in 
controlling the equilibrium potential of chloride ions (ECl-) in neurons (Blaesse et al. 2009, 
Delpire 2000, Payne et al. 2003). In other words, maintenance of ECl- and induction of 
changes in it are thought to be dependent on opposing actions of chloride extrusion by KCC2 
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and chloride accumulation by NKCC1. Therefore, these two Cl- cotransporters directly 
influence the balance of [Cl-]i and  depending  on  their  relative  activities,  set  ECl- either  to  
hyperpolarizing or depolarizing in a spatio-temporal manner (Fig.1). 
In  addition  to  its  role  in  maintaining  a  low  [Cl-]i for GABAergic 
hyperpolarizing responses, KCC2 has also been implicated in the regulation of neuronal 
migration, dendrite outgrowth and formation of excitatory and inhibitory synaptic 
connections. These functions might dependent on Cl- efflux activity of KCC2 as well  as its  
ability to interact with cytoskeletal elements (see section 1.2.2.4).  
 
 
Fig.1. Ion-transport mechanisms underlying GABAAR-mediated responses.  
(Left) The dominant cation chloride cotransporter NKCC1 mediates Cl- uptake in immature 
neurons, creating a depolarizing ECl-.  Ionotropic  GABAAR mediates outward directed Cl- 
currents. (Right) In mature neurons, KCC2 acts as the principle cation chloride cotransporter 
and extrudes Cl-, setting a hyperpolarizing ECl-. GABAAR now allows passage of Cl- into the 
cell. Transport by both NKCC1 and KCC2 is fuelled by Na+ and  K+ gradients generated by 
the Na+-K+ ATPase.   
 
1.2.2.1  KCC2 and GABAAR hyperpolarizing inhibition 
As stated, in the adult mammalian CNS, fast inhibitory neurotransmission is 
mediated predominantly by GABAAR and GlyR, which conduct Cl- down its electrochemical 
gradient. For hyperpolarizing currents through GABAAR  and  GlyR,  maintenance  of  a  low  
[Cl-]i (i.e.  setting  ECl- at more negative values than the resting membrane potential) is 
required so that inward Cl- flux through these channels can stabilize the membrane potential 
15 
 
at or near the ECl-.  If  ECl- is set above the resting membrane potential, currents through 
GABAAR and GlyR can be depolarizing and even excitatory as activated GABAAR and GlyR 
would  allow  Cl- to  flow  out  of  the  cell  (see  Fig.1).  In  developing  neurons,  GABA  is  
depolarizing (Ben-Ari 2002, Ben-Ari et al. 1989, Cherubini et al. 1991) which is due to a low 
expression/function of KCC2 and an under-developed chloride extrusion pathway. ECl- is set 
above the resting membrane potential mainly by the predominating chloride influx activity of 
NKCC1 (Achilles et al. 2007, Brumback and Staley 2008, Kakazu et al. 1999, Sipila et al. 
2006, Spitzer 2010, Yamada et al. 2004). As there is a developmental increase in KCC2 
expression/function, the relative contribution of chloride extrusion activity of KCC2 in 
setting the [Cl-]i is increased so much so that in mature neurons, ECl- is set below the resting 
membrane potential (Bray and Mynlieff 2009, DeFazio et al. 2000, Hubner et al. 2001, Li H. 
et al. 2002, Rivera et al. 1999, 2005, Stein et al. 2004, Zhu L. et al. 2008, but see Delpy et al. 
2008), causing a shift in GABAergic (and glycinergic) responses from depolarizing to 
hyperpolarizing (see Fig.1). This shift in GABAergic signaling occurs during early 
development (first two postnatal weeks in rats). Several studies using different approaches 
have established a key role of KCC2 in this developmental shift. Consistently, knocking out 
KCC2 expression (Hubner et al. 2001, Zhu L. et al. 2005), or knocking out KCC2b 
expression alone (Balakrishnan et al. 2003, Stil et al. 2011, Woo et al. 2002) or knock down 
of  KCC2 expression (Pellegrino et al. 2011, Rivera et al. 1999) prevents or attenuates the 
shift  of  EGABA-A from depolarizing to hyperpolarizing. Along similar lines, pharmacological 
blockade of KCC2 leads to increased [Cl-]i levels that can revert the equilibrium potential of 
GABAAR (EGABA-A) from hyperpolarizing to depolarizing (DeFazio et al. 2000, Jarolimek et 
al. 1999, Martina et al. 2001). On the other hand, over-expression of KCC2 in immature 
neurons leads to decreased [Cl-]i levels and a premature shift in EGABA-A from depolarizing to 
hyperpolarizing (Akerman and Cline 2006, Cancedda et al. 2007, Chudotvorova et al. 2005, 
Fiumelli et al. 2005, Lee H. et al. 2005, Reynolds et al. 2008). Moreover, mature neurons that 
have  preserved  the  depolarizing  GABA  responses  or  have  reduced  efficiency  of  GABA  
mediated inhibition have been shown to have high levels of [Cl-]i in association with low 
levels of KCC2 expression/function (Banke and McBain 2006, Bartho et al. 2004, Gulacsi et 
al. 2003, Ikeda M. et al. 2003, Kanaka et al. 2001, Pozas et al. 2008, Toyoda et al. 2005, 
Ueno et al. 2002, Wang C. et al. 2002, 2005, Vu et al. 2000). In conclusion, it seems like 
developmental up-regulation of KCC2 expression/function contributes largely to the shift in 
depolarizing GABA actions to hyperpolarizing. Moreover, changes in KCC2 function in 
mature neurons is an effective strategy employed by many neuronal systems in inducing 
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plasticity of inhibitory GABAergic signaling by changes in the [Cl-]i (see sections 1.2.2.2 and 
1.5). 
While the contribution of up-regulation of KCC2 expression/function in the 
shift of GABA and glycine signaling is well-established, a concomitant down-regulation of 
NKCC1 function has also been proposed as a contributing factor but has however not been 
consistently observed (Blaesse et al. 2009). It is relevant to explain the depolarizing and 
hyperpolarizing actions of GABA based on relative activities of NKCC1 and KCC2 
expressed in the plasma membrane in a spatio-temporal manner rather than relying on the 
absolute expressions of NKCC1 and KCC2 proteins in a neuron (Deisz et al. 2011, Delpy et 
al. 2008, Gilbert et al. 2007, Marty S. et al. 2002, Vardi et al. 2000, Zhang L. L. et al. 2006). 
Consistently, distinct sub-cellular localization of KCC2 in soma and dendrites and NKCC1 in 
axons has been proposed to result in generation of intraneuronal Cl- gradients and differential 
GABAergic responses (Banke and McBain 2006, Gavrikov et al. 2006, Jarolimek et al. 1999, 
Khirug et al. 2008, Szabadics et al. 2006, Vardi et al. 2000, Vu et al. 2000). 
Interestingly, both GABAAR  and  GlyR  can  also  contribute  to  inhibitory  
transmission by shunting mechanism which is independent of the direction of the Cl- currents 
(Banke and McBain 2006, Ben-Ari 2002, Farrant and Kaila 2007, Owens and Kriegstein 
2002). Indeed, while the depolarization induced by postsynaptic GABAAR currents can lead 
to excitation of the neuron, it can also cause shunting inhibition of glutamatergic currents 
(Lamsa et al. 2000, Palva et al. 2000). Moreover, GABAAR (and GlyR) is also permeable to 
HCO3- and  these  HCO3- currents can significantly contribute to postsynaptic responses of 
GABAAR under certain physiological (Kaila et al. 1987, Kaila 1993, Viitanen et al, 2010) 
and pathophysiological (Asiedu et al. 2010) conditions in neurons with a reduced Cl- 
extrusion capacity. In spite of EGABA-A not being identical to ECl- but showing a deviation to 
more positive values due to permeability to HCO3-, EGABA-A is nevertheless mainly set by Cl- 
gradient across the neuronal membrane (Blaesse et al. 2009, Farrant and Kaila 2007, Kaila 
1994).       
 
1.2.2.2  Neuronal pathologies and KCC2  
Synaptic modification in physiological and pathophysiological conditions is 
critical for both proper functioning of the nervous system and its response to stress and 
trauma. A decrease in the strength of inhibitory GABAergic transmission has been observed 
after neuronal trauma and other neuronal pathologies and stresses. An altered intracellular Cl- 
homeostasis has been shown to contribute to this decrease in inhibitory GABA signaling (and 
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even an increase in its depolarizing actions) in several studies (De Koninck 2007, Payne et al. 
2003, van den Pol et al. 1996). There are reports of decreased KCC2 expression/function in 
various nervous system pathologies and diseases like neuronal injury and trauma 
(Bonislawski et al. 2007, Jin et al. 2005, Nabekura et al. 2002, Toyoda et al. 2003); in vivo 
(Barmashenko et al. 2011, de Guzman et al. 2006, Lee H. H. et al. 2010, Li X. et al. 2008, 
Pathak et al. 2007, Rivera et al. 2002, Robinson et al. 2010, Shimizu-Okabe et al. 2007, 
Shulga et al. 2008, but see Mao et al. 2011, Shin et al. 2011, Zhu X. et al. 2012) and in vitro 
(Nardou et al. 2011, Rivera et al. 2004, Wake et al. 2007, Study III) seizure models, and 
human epileptic tissue (Aronica et al. 2007, Deisz et al. 2011, Huberfeld et al. 2007, 
Munakata et al. 2007, Munoz et al. 2007, Palma et al. 2006, Shimizu-Okabe et al. 2011); 
glutamate excitotoxicity (Lee H. H. et al. 2011, Study III); oxidative stress (Wake et al. 
2007); ischemic brain injury/oxygen-glucose deprivation (Galeffi et al. 2004, Hershfinkel et 
al. 2009, Jaenisch et al. 2010, Papp et al. 2008, but see Reid et al. 2000, 2001); Alzheimer-
like neurodegenerative pathology (Lagostena et al. 2010); a rodent model of schizophrenia 
(Liu Y. et al. 2009) and brain tissue from human schizophrenic patients (Hyde et al. 2011); a 
mouse model of amytrophic lateral sclerosis (ALS) (Fuchs et al. 2010); deafness (Vale et al. 
2003); stress (Hewitt et al. 2009, Matrisciano et al. 2010, Sarkar et al. 2011, Tornberg et al. 
2005, but see Galanopoulou 2008c); and spinal cord injury-induced neuropathic (Boulenguez 
et al. 2010, Coull et al. 2003, 2005, Cramer et al. 2008, Hasbargen et al. 2010, Janssen et al. 
2011, 2012, Jean-Xavier et al. 2006, Jolivalt et al. 2008, Lu Y. et al. 2008, Miletic and 
Miletic 2008, Price et al. 2009, but see Tornberg et al. 2005) and peripheral inflammatory 
pain (Nomura et al. 2006, Zhang W. et al. 2008).  
The depolarizing nature of GABA signaling in models of neuronal trauma and 
pathologies is associated with an increase in intracellular Ca2+ ([Ca2+]i) mainly through Ca2+ 
influx via the voltage gated calcium channels (VGCCs) (Nabekura et al. 2002, Shulga et al. 
2008, Toyoda et al. 2003, van den Pol et al. 1996). During development, depolarizing GABA 
responses promote Ca2+ influx through voltage and glutamate gated calcium channels 
(NMDAR) which contribute to different aspects of neural circuit maturation and refinement 
including neuronal proliferation and migration, morphological development, and neurite 
growth and synaptogenesis (Akerman and Cline 2007, Ben-Ari 2002, Ben-Ari et al. 2007, 
Farrant and Kaila 2007, Fiumelli and Woodin 2007, Galanopoulou 2008b, Ge et al. 2007, 
Owens and Kriegstein 2002, Represa and Ben-Ari 2005, Wang D. D. and Kriegstein 2009). 
Depolarizing GABA in immature neurons is also known to induce BDNF expression and 
release in Ca2+-dependent manner (Berninger et al. 1995, Porcher et al. 2011) which might 
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also augment the trophic effects of GABA on developing neuronal networks (Owens and 
Kriegstein 2002, Porcher et al. 2011). Interestingly, hyperpolarizing GABAergic responses in 
mature neurons do not elicit an increased BDNF secretion but actually depress the latter’s 
expression levels consistent with the hyperpolarizing action of the GABAergic signaling in 
reducing [Ca2+]i via inactivation of the L-type VGCCs (Berninger et  al.  1995, Porcher et  al.  
2011).  
Along similar lines, premature over-expression of KCC2 and consequent 
absence of depolarizing glycinergic actions in zebrafish embryos is thought to impair 
neurogenesis and neuronal differentiation (Reynolds et al. 2008). An up-regulation of 
functional KCC2 has been found to be necessary to reduce neuronal motility since it acts as a 
switch in transforming GABA from a motogenic to a stop signal in migrating neurons 
(Bortone and Polleux 2009). Even in adult neurogenic niches, a similar pattern of GABA 
signaling is observed (Ge et al. 2006, Reali et al. 2011, Reynolds et al. 2008). In addition, 
since migrating cells have a higher [Cl-]i than settled cells (Bortone and Polleux 2009, 
Shimizu-Okabe et al. 2002, 2007), a decreased KCC2 function might be involved in 
migration of neurons in the injured area. A hyperpolarizing to depolarizing shift of GABA 
signaling and a consequent shift in GABA-mediated BDNF regulation after neuronal trauma 
and pathology might propel back the surviving neurons into a state of immaturity with greater 
potential for reformation, re-growth and refinement of neuronal networks after traumatic 
insults to the mature neuronal networks. Consistently, a number of groups have suggested 
that a functional decrease in KCC2 and the concomitant shift in GABA responses to 
depolarizing (or a decrease in its inhibitory hyperpolarizing responses) as well as a change in 
composition of GABAAR subunit-composition resembling the development-like state in 
models of neuronal trauma may be associated with neuronal survival, regeneration and re-
establishment of functional connectivity (Cohen et al. 2003, Kahle et al. 2008, Nabekura et 
al. 2002, Payne et al. 2003, Shulga et al. 2008, 2009, Toyoda et al. 2003, van den Pol et al. 
1996). On the other hand, uncontrolled increase in Ca2+ influx mediated by depolarizing 
GABAergic actions in pathophysiological conditions can facilitate activation of neuronal 
degradation and death; an increased risk of excitotoxicity-induced neuronal degradation; 
secondary neuronal injury; and pathogenesis of seizure and neuropathic pain (Aronica et al. 
2007, Austin and Delpire 2011, Briggs and Galanopoulou 2011, Cohen et al. 2002, 2003, 
Coull et al. 2005, Fuchs et al. 2010, Galeffi et al. 2000, Jaenisch et al. 2010, Jin et al. 2005, 
Jolivalt et al. 2008, Kahle et al. 2008, Khalilov et al. 2005, Lee H. H. et al. 2011, Malek et al. 
2003, Mao et al. 2011, 2012, Molinaro et al. 2008, Munakata et al. 2007, Nardou et al. 2011, 
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Pathak et al. 2007, Pellegrino et al. 2011, Pond et al. 2004, Schwartz-Bloom and Sah 2001, 
Shin et al. 2011, van den Pol et al. 1996).    
However there are certain key aspects of GABAergic signaling that have to be 
considered before ascertaining the physiological relevance of KCC2 down-regulation and a 
decreased GABAergic inhibition in pathological conditions. GABAergic synapses of mature 
neuronal circuits operate very close to their switch point. The consequences of GABAergic 
signaling in a neuronal network is quite complicated and context-dependent in relation to the 
resting membrane potential, temporal and spatial aspects of excitatory inputs, the 
heterogeneity of GABAergic neurons and the inter- and intra-neuronal differences in 
intracellular Cl- concentration as well as activity-mediated fast changes in the chloride 
homeostasis and an increase in the physiological significance of its HCO3- conductance (Ben-
Ari and Holmes 2005, Cossart et al. 2005, De Koninck 2007, Farrant and Kaila 2007, Ikeda 
M. et al. 2003, Martina et al. 2001, Marty A. and Llano 2005, Owens and Kriegstein 2002, 
Prescott et al. 2006, Rivera et al. 2005, Staley and Mody 1992, Staley et al. 1995, Tyagarajan 
and Fritschy 2010, Viitanen et al. 2010, Wright et al. 2011). In addition, the ability of KCC2 
to reverse its direction of cotransport under conditions of high extracellular K+ (see section 
1.2.2.3) that accompany increased neuronal excitability in models of neuronal pathologies, 
makes  it  difficult  to  predict  whether  a  functional  down-regulation  of  KCC2 is  beneficial  or  
detrimental with certainty. Moreover, the effect of structural interaction of KCC2 with the 
dendritic cytoskeletal proteins (see section 1.2.2.4) might add an increased facet in the 
pathological consequences of KCC2 degradation in neuronal trauma and excitotoxicity.           
Nevertheless, there are both reports that suggest that a down-regulated KCC2 
function and a depolarizing GABAergic signaling might aid the survival and regeneration of 
neurons as well as those that suggest that KCC2 down-regulation might contribute to a 
decreased survival and susceptibility of neurons after trauma and other pathologies. Wake et 
al. (2007) found a decreased viability of cells over-expressing KCC2 in a model of H2O2-
induced neuronal oxidative stress. While co-application of GABAAR agonists during H2O2 
incubation was shown to exacerbate neuronal death, GABA antagonists increased the cell 
viability (Wake et al. 2007). Maintenance of an increased [Cl-]i by an up-regulation of 
NKCC1 in the injured sensory neurons (which lack KCC2) has been shown to contribute to 
neuronal regeneration of these injured neurons (Pieraut et al. 2007, 2011). Recently, 
Pellegrino et al. (2011) have demonstrated that suppression of KCC2 expression and function 
increased the susceptibility of neurons to oxidative stress and excitotoxicity, while over-
expression of functional KCC2 could rescue the neuronal resistance, suggesting that 
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maintenance of functional KCC2 is essential for neuronal survival after excitotoxic insults. In 
a model of excitotoxic insult, reduced expression of KCC2 by BDNF-pretreatment rendered 
GABAAR agonists neurotoxic which otherwise were neuroprotective in control neurons 
(Molinaro et al. 2008). An increase in the extracellular Cl- concentration abolished the 
neurotoxic effect of the GABAAR agonists in the BDNF-pretreated neurons, while down-
regulation of KCC2 expression prevented the neuroprotective action in controls neurons 
imposed on with an excitotoxic insult (Molinaro et al. 2008). Neuroprotective action of 
topiramate against neuronal death in a cerebral ischemia model of brain injury was associated 
with increased GABAergic inhibitory transmission including an increased expression of 
KCC2 (Mao et al. 2012). Interestingly, post-traumatic hippocampal neurons become 
dependent on BDNF trophic support for their survival and this dependence is attributed to 
depolarizing GABAergic actions that induce intracellular Ca2+ increase  and  cause  an  
upregulation of pan-neurotrophin receptor p75(NTR) (Shulga et al. 2008, 2009, 2012). While 
recovery from neuronal injury coincides with the recovery of KCC2 expression and function 
and at this stage the trophic support of BDNF for neuronal survival is no longer required 
(Shulga et al. 2008), a functional block of NKCC1 can be neuroprotective and abolishes the 
dependency of the injured neurons for BDNF (Shulga et al. 2012). Probably, KCC2 down-
regulation and a decrease in the inhibitory GABAergic signaling have multifaceted 
consequences  on  the  neuronal  system  that  depend  on  the  type,  severity  and  stage  of  the  
trauma as well as on the neuronal type involved.  
  
1.2.2.3  Reversibility of KCC2 cotransport  
In addition to the activity-dependent decrease of hyperpolarizing GABAergic 
signaling by functional down-regulation of KCC2 and a consequent increase in [Cl-]i, KCC2 
has also been proposed to result in substantial decrease in the strength of inhibitory 
GABAergic signaling by acting as a chloride uptake mechanism in event of increased 
extracellular K+ associated  with  heightened  neuronal  activity  (Kaila  1994,  Vinay  and  Jean-
Xavier 2008). This property of KCC2 derives from operation of its cotransport function near 
equilibrium close to the physiological levels of [Cl-]i and [K+]o (Farrant and Kaila 2007, 
Payne 1997, Payne et al. 2003, Rivera et al. 2005). Hence, during periods of high neuronal 
activity, KCC2 can function as a net K+-Cl- influx pathway, thereby reducing the 
extracellular K+ levels while at the same time increasing intracellular Cl- levels leading to a 
positive shift in EGABA-A and a compromised inhibition (Cordero-Erausquin et al. 2005, 
Kakazu et al. 2000, Payne et al. 2003). The reversibility of KCC2 cotransport has been 
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verified experimentally (DeFazio et al. 2000, Hershfinkel et al. 2009, Jarolimek et al. 1999, 
Kakazu et al. 2000, Viitanen et al. 2010), and may explain activity-dependent decline of 
inhibitory signaling (Ling and Benardo 1995, Thompson and Gahwiler 1989), whereby 
repetitive GABAergic transmission results in a biphasic response of GABAAR  to  GABA  
(hyperpolarization followed by a prolonged depolarization). In addition, due to a reduced Cl- 
driving force in response to high frequency stimulation, depolarizing HCO3- currents through 
GABAAR and associated K+ transients will also aid in this kind of diminishment of inhibitory 
signaling (Cordero-Erausquin et al. 2005, Kaila et al. 1993, 1997, Viitanen et al. 2010).       
  
1.2.2.4  Structural roles of KCC2   
Presence of KCC2 in dendrites and soma which are the main targets of 
inhibitory inputs (Chattopadhyaya et al. 2004, Szabadics et al. 2006) are explainable by the 
chloride extrusion function of KCC2 necessary for maturation of inhibitory GABAergic 
synapses (see section 1.2.2.1). What was intriguing however, was a high KCC2 expression in 
dendritic spines (Gulyas et al. 2001) which are major postsynaptic targets of glutamatergic 
inputs (Freund and Buzsaki 1996). Only recently however a cotransport independent 
structural  role  for  KCC2 in  spine  formation  and  development  of  excitatory  synapses,  based  
upon its interaction with protein 4.1N that acts as a scaffold for cytoskeletal interaction with 
trans-membrane proteins, has been proposed (Li H. et al. 2007). Hence, spine maturation was 
altered (observable as long, irregularly branched and highly motile dendritic protrusions) and 
functional excitatory synapses were reduced in KCC2-deficient mice and these abnormalities 
could be rescued by expression of transport inactive KCC2 mutant (Li H. et al. 2007). On the 
other hand, suppression of KCC2 expression in mature neurons reduced the efficiency of 
excitatory neurotransmission by changes in AMPA receptor (AMPAR) membrane 
distribution in a cotransport independent manner (Gauvain et al. 2011). Premature expression 
of KCC2 has been shown to cause alterations in dendritic growth and branching, reduced 
synaptogenesis and impaired neuronal differentiation and maturation (Akerman and Cline 
2006, Cancedda et al. 2007, Lee H. et al. 2005, Reynolds et al. 2008) which has been 
attributed to a premature decrease in [Cl-]i and a consequent reduction in GABA 
depolarization. However, Horn et al. (2010) have implicated a structural role of KCC2 in 
inducing changes in the cytoskeletal arrangements in the morphological alterations observed 
upon premature KCC2 expression. They concluded that previous studies based their 
inferences on involvement of cotransport activity of KCC2 using a transport-inactive mutant 
(C568A) of KCC2 (Cancedda et al. 2007, Reynolds et al. 2008) which also had a reduced 
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affinity for 4.1N (Horn et al. 2010). Along similar lines, pre-mature over-expression of KCC2 
resulted in a permanent increase in spine density in cortical neurons (Fiumelli et al. 2012). 
Since the effect could be replicated by over-expression of both the transport inactive N-
terminal deleted KCC2 as well as the C-terminal domain of KCC2 but not the C568A KCC2 
mutant, the authors proposed an ion-transport independent structural role of KCC2 in 
excitatory synaptogensis (Fiumelli et al. 2012).  However, the structural role of KCC2 cannot 
alone explain the alterations in neuronal differentiation and maturation in systems with 
prematurely over-expressed KCC2 based on studies that implicate depolarizing GABA 
effects which in turn depend on a reduced KCC2 cotransport function (Akerman and Cline 
2006, Bortone and Polleux 2009) and studies showing that a reduced excitation in immature 
neurons by over-expression of inward-rectifier K+ channel Kir2.1  can  mimic  the  effects  of  
premature KCC2 over-expression (Cancedda et al. 2007). Hence, the effects observed in the 
studies with premature KCC2 over-expression on excitatory signaling seem to involve both 
its transport-dependent function and its ability to physically interact with 4.1N to change the 
cytoskeletal elements (Medina and Chudotvorova 2006). Interestingly, a functional blockade 
of NKCC1 cotransport and hence a lack of depolarizing GABAergic signaling during a 
critical period has recently been shown to induce changes in the morphology, density and 
branching of dendrites (Wang D. D. and Kriegstein 2008, 2011) which might also be 
explained by a proposed transport independent role of NKCC1 in embryo morphogenesis 
(Walters et al. 2009). 
Recently, endogenous KCC2 has been proposed to regulate synaptogenesis 
even during embryonic stage when its expression is very low. Indeed, deletion of SLC12A5 
causes an increased GABAergic and glutamatergic synaptogenesis and increased 
postsynaptic currents (Khalilov et al. 2011). Although the mechanism by which KCC2 can 
regulate synaptogenesis in the embryonic stage when it is thought to be incapable of K+-Cl- 
cotransport in most neurons was not studied, the authors proposed that either the structural 
role of KCC2 or the cotransport function of KCC2 in a sub-population of neurons could be 
important (Khalilov et al. 2011).     
A physical interaction of KCC2 and 4.1N may actually have a more far-
reaching corollary than glutamatergic synaptogenesis alone. As shown for several plasma 
membrane proteins that interact with cytoskeletal elements (Bennett and Baines 2001, Denker 
and Barber 2002), such an interaction can serve as a functional and/or organizational protein-
protein interaction-mediated regulatory mechanism for KCC2 itself and hence may contribute 
to GABAergic synaptogenesis (Akerman and Cline 2006, Chudotvorova et al. 2005) both 
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structurally and functionally. Importantly, presence of a K+-Cl- cotransport inactive KCC2 
early in the development (Balakrishnan et al. 2003, Blaesse et al. 2006, Lohrke et al. 2005, 
Milenkovic et al. 2007, Vale et al. 2005) may be explained by the morphogenic and structural 
role played by KCC2 in synapse formation and refinement. Thus, premature expression of 
KCC2 facilitates formation of functional GABAergic synapses by increasing the density of 
GABAARs (Akerman and Cline 2006, Chudotvorova et al. 2005). Although a decreased [Cl-]i 
level mediated by KCC2 chloride extrusion has been proposed to be the basis of this 
developmental maturation of GABAergic synapses (Akerman and Cline 2006, Chudotvorova 
et  al.  2005),  a  structural  role  of  KCC2  as  an  interacting  partner  with  cytoskeletal  elements  
and GABAAR  (Huang  Y.  et  al.  2012)  might  be  interesting  to  examine.  Interestingly,  a  
cotransport independent structural role of KCC2 modulation of the cytoskeletal elements has 
been found to promote migration and metastasis of cancerous cells (Wei et al. 2011). 
In  conclusion,  KCC2  seems  to  affect  excitatory  synaptogenesis  directly  and  
independent of the depolarizing GABA-mediated effects (Andang and Lendahl 2008, 
Gauvain et al. 2011, Horn et al. 2010, Li H. et al. 2007). Hence, because of its involvement in 
maturation of both inhibitory and excitatory neurotransmission, KCC2 might act as a 
synchronizing factor for functional development of excitatory and inhibitory 
neurotransmission (Akerman and Cline 2006, 2007, Ben-Ari 2002, Kanold and Shatz 2006, 
Li H. et al. 2007).  
 
1.3 Regulation of KCC2 protein synthesis  
Since  KCC2  is  a  key  molecule  involved  in  the  developmental  shift  of  GABA  
signaling in the CNS (see section 1.2.2.1), it is under tight translational regulation during 
early development and indeed, a number of factors have been implicated in regulation of 
KCC2 protein synthesis during development. Developmental up-regulation of KCC2 function 
in rodent cortical and hippocampal neurons is mainly under transcriptional control. However, 
there is strong evidence for post-translational regulation of KCC2 function in triggering the 
GABA  shift  as  well.  This  and  the  next  sections  outline  the  factors  that  regulate  KCC2  
function by translational and post-translational mechanisms.   
 
1.3.1 Regulation of KCC2 expression by transcription factors  
A number of transcriptional regulatory sites have been identified in the KCC2 
encoding SLC12A5 gene that are thought to be critical for the control of KCC2 expression. 
These include an E-box element, a dual repressor element-1 (RE-1) site and an early growth 
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response 4 (Egr4) element. As discussed above, KCC2 has a neuron-specific expression (see 
section 1.2.1) which was initially attributed to a neuron-restrictive silencer element (NRSE) 
or repressor element-1 (RE-1) in intron 1 of the SLC125A gene that binds to a silencing 
factor  restrictive  to  neurons  (neuronal  restrictive  silencing  factor,  NRSF;  also  known  as  
repressor element-1 transcription factor, REST complex) and hence does not allow the 
transcription of genes in non-neuronal cells (Karadsheh and Delpire 2001). Other studies 
have confirmed a REST-mediated transcription inhibition of the SLC12A5 gene via the RE-1 
(Uvarov et al. 2005, Yeo et al. 2009), however the absolute dependence of a RE-1 and REST 
interaction for the neuron-specific expression of KCC2 is uncertain (Uvarov et al. 2005). 
Instead of the RE-1 site, a 1.4-kb promoter region upstream of the NRSE-containing intron 1 
has  been  argued  to  be  sufficient  in  driving  the  neuron-specific  expression  pattern  of  KCC2 
(Uvarov et al. 2005). A transcription factor, early growth response protein 4 (Erg4) that binds 
to SLC12A5 regulatory sequences and positively regulates KCC2 expression, may serve as a 
contributing factor in specifying the neuron-restricted expression of KCC2, since Egr4 is 
highly enriched in neurons (Uvarov et al. 2006). Based upon a similar temporal expression 
pattern of Egr4 and KCC2, the former might also regulate the developmental increase in 
KCC2 protein (Uvarov et al. 2006). The dual RE-1?REST complex interactions have also 
been implicated in the up-regulation of KCC2 during postnatal development (Yeo et al. 
2009). Lastly, the E-box in the SLC12A5 promoter has also been demonstrated to influence 
its transcription by interactions with the upstream stimulating factors (USF proteins) 
(Markkanen et al. 2008).  
In addition to the transcription factors that can regulate production of KCC2 
mRNAs, the stability of KCC2 mRNAs itself has also been recently shown to be modulated 
by microRNAs which are non-coding RNA molecules that can regulate gene expression 
(Bartel 2004). MicroRNA-92 was found to physically interact with KCC2 mRNA and reduce 
its translation (Barbato et al. 2010). Since microRNA-92 is developmentally down-regulated, 
it might constitute another cellular mechanism employed in a tight regulation of KCC2 
protein expression during development (Barbato et al. 2010).  
Lastly, steroid hormones that can act as transcription factors have been shown 
to  regulate  the  expression  of  KCC2.  Male  sex  hormone  testosterone  was  found  to  increase  
KCC2 expression during development in both sexes while 17?-estradiol decreased KCC2 
expression only in neurons with a depolarizing GABAergic signaling in a Ca2+-dependent 
manner (Galanopoulou 2006, 2008a, Galanopoulou and Moshe 2003). The mechanisms 
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however, have not been deduced for these hormonal regulations of KCC2 translational 
changes, although transcription factor cAMP response element-binding protein (CREB) has 
been implicated (Galanopoulou 2006). Another hormone triiodothyronine (physiologically 
active form of thyroid hormone thyroxin) which is an amino acid derivative can up-regulate 
KCC2 functionally during development most probably by post-translational modifications 
(Friauf et al. 2008), as well as in injured mature neurons (Shulga et al. 2009). Interesting, in 
adult neurons, thyroxin has been shown to down-regulate KCC2 expression (Shulga et al. 
2009).            
 
1.3.2 Regulation of KCC2 expression by neurotrophic factors  
Neurotrophic factors play crucial roles in the development of the CNS. They 
have widespread effects on factors governing CNS development such as neuronal survival, 
neuronal precursor cell differentiation, neurite outgrowth, synaptogenesis and maturation of 
neuronal function (Huang E. J. and Reichardt 2003). Hence, the role of neurotrophic factors 
in regulating KCC2 expression during development is but expected, considering the essential 
role KCC2 plays in maturation of inhibitory signaling and in structural organization of 
synapses.  
The contribution of brain-derived neurotrophic factor (BDNF) in regulating the 
expression of KCC2 has been well documented both in the developing and mature neurons. 
The involvement of BDNF in the developmental up-regulation of KCC2 protein has been 
proposed by a number of studies (Aguado et al. 2003, Carmona et al. 2006, Ludwig et al. 
2011a, 2011b, Rivera et al. 2004, Yeo et al. 2009). Both BDNF and neurturin contribute to an 
expressional increase in KCC2 transcription through the action on transcription factor Erg4 
(Ludwig et al. 2011a, 2011b). BDNF has also been shown to remove the inhibition of REST 
complex on the dual RE-1 site present in the SLC12A5 gene (Yeo et al. 2009). In addition to 
BDNF, other trophic factors that act via tyrosine kinase receptors, such as insulin like growth 
factor-1 (Kelsch et al. 2001) and nerve growth factor (NGF) (Lagostena et al. 2010) have also 
been implicated in functional and expressional regulation of KCC2 during development. 
Interestingly, trophic actions of depolarizing GABA that can cause a Ca2+ influx through 
VGCCs in immature neurons have been implicated in the developmental up-regulation of 
KCC2 expression (Ganguly et al. 2001, Kriegstein and Owens 2001, Leitch et al. 2005). 
However, this view has been refuted by others (Ludwig et al. 2003, Pfeffer et al. 2009, Sipila 
et al. 2009, Titz et al. 2003, Wojcik et al. 2006).   
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As opposed to up-regulatory action of BDNF on KCC2 expression in immature 
neurons, in the adult brain, BDNF was shown to have an opposite effect of rapid down-
regulation of KCC2 function (Huang Y. et al. 2012, Wardle and Poo 2003) and a more 
sustained down-regulation of its mRNA and protein (Molinaro et al. 2008, 2009, Rivera et al. 
2002, 2004). Interesting, both positive and negative regulation of KCC2 expression by BDNF 
have been shown to be dependent on tropomyosin receptor kinase B (TrkB) signaling (Huang 
Y. et al. 2012, Rivera et al. 2004, Wardle and Poo 2003). Rivera et al. (2004) have proposed 
that the opposing effects of BDNF in the developing vs. the mature brain are due to activation 
of different downstream signaling cascades by TrkB receptors. Interestingly, like its role in 
up-regulation of KCC2 during development, BDNF can cause an expressional and functional 
up-regulation of KCC2 in injured mature neurons (Boulenguez et al. 2010, Shulga et al. 
2008).  
 
1.4 Post-translational regulation of KCC2 function 
Recent studies are just beginning to elucidate the role of post-translational 
regulation in controlling KCC2 function both in its developmental up-regulation 
(Balakrishnan et al. 2003, Blaesse et al. 2006, Friauf et al. 2008, Hartmann et al. 2009, 
Kelsch et al. 2001, Khirug et al. 2005, Lohrke et al. 2005, Milenkovic et al. 2007, Rinehart et 
al. 2009, Vale et al. 2005) and its down-regulation in neuropathological conditions (Fiumelli 
et al. 2005, Hewitt et al. 2009, Jin et al. 2005, Lee H. H. et al. 2010, 2011, Sarkar et al. 2011, 
Vale et al. 2003, Study III). Like most other proteins, functional regulation of KCC2 at the 
post-translational level can be attributed to modifications in its interaction with self/other 
proteins, sub-cellular targeting, changes in phosphorylation states and protein degradation. 
These categories have been discussed separately. However, the division is purely aesthetic 
and there is no reason to assume them to be independent of each other. Actually, there are 
examples where two or more strategies may be inter-related (see below).  
For KCC2, the large intracellular C-terminal domain harbors the major sites of 
regulation and conformational stability determinants, the latter not being independent of 
regulatory protein-protein interactions (Adragna et al. 2004, Bergeron et al. 2006, Strange et 
al. 2000). Consistently, cotransport function of KCC2 is lost on modifications in the C-
terminal domain (Casula et al. 2001, Strange et al. 2000). Although KCC2 cotransport is also 
abolished upon deletion of its N-terminus (Li H. et al. 2007), relatively little is known how 
the  N-terminal  domain  of  KCC2  affects  its  cotransport  function.  Some  important  proposed  
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post-translational mechanisms that are thought to regulate KCC2 cotransport have been 
summarized at the end of section 1.4.4.1 (See Fig. 2).      
 
1.4.1 Regulation of KCC2 activity by protein-protein interaction  
Regulation of function of a protein by modulation in its interaction with other 
proteins is a common phenomenon in cellular biology. The protein-protein interactions can 
affect the function of a protein in several ways. They can modulate the sub-cellular 
distribution of the protein by acting as a scaffolding and/or stabilizing factor in relation to its 
accessibility to accessory proteins, substrates and cofactors and aid in formation of physical 
complexes or functionally-coupled protein units for the proper functioning in a cellular 
micro-environment. Protein-protein interactions can also act as a means of allosteric 
modulation of the protein function. Even though the large intracellular C-terminal domain of 
KCC2, based upon conservation of its sequence across species, is thought to play a key role 
in maintaining the functional conformation of KCC2 and in mediating protein-protein 
interactions that can regulate KCC2 cotransport function, very little is known about how 
other proteins interact with it to modulate its function.  
KCC2 was found to co-localize with GABAAR receptors (Belenky et al. 2008, 
Gulacsi et al. 2003, Williams et al. 1999, Vu et al. 2000) and gephyrin, which clusters 
GABAAR and GlyR (Gulyas et al. 2001, Tyagarajan and Fritschy 2010), however evidence 
for a physical interaction between KCC2 and GABAAR  was  provided  only  recently  by  co-
immunoprecipitation (Huang Y. et al. 2012). Brain-type creatine kinase (CKB) has been 
shown to physically interact with KCC2 and to enhance its chloride extrusion activity (Inoue 
et al. 2004, 2006). Although there is no evidence that CKB directly phosphorylates KCC2 or 
influences its total protein or surface expression, it might regulate KCC2 indirectly by its 
proposed role in regeneration of ATP necessary for ion-driving force of KCC2 for K+-Cl- 
cotransport  (see  section  1.2.2.1).  Moreover,  since  CKB does  not  seem to  change  the  global  
ATP levels in the cells, its indirect ‘thermodynamic action’ on KCC2 function (Payne et al. 
2003) might represent its ability to change local ATP levels (Inoue et al. 2004, 2006). Indeed, 
the formation of functionally coupled units operating in small micro-environments in the cell 
membrane seems quite a successful cellular mechanism for maximal utilization of resources, 
as has also been shown in a study dealing with physical interactions between KCC2 and Na+-
K+ ATPase ?2 subunit and its consequences (Ikeda K. et al. 2004). The ?2 isoform was found 
to play a crucial role in Cl- homeostasis, not compensated for by the ?1 and ?3 isoforms. 
Moreover, like the KCC2-CKB interaction discussed above, the functional interaction of 
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Na+-K+ ATPase ?2 with KCC2 did not depend on changes in the latter’s protein levels but 
might have affected KCC2 function thermodynamically by changes in the local K+ gradient 
(Ikeda K. et al. 2004). Although it is the ?3 isoform that has a characteristic neuron-specific 
expression (Cameron et al. 1994), the ?2 isoform is known to be expressed in embryonic 
neurons and speculated to be an important modulator of neuronal activity in the neonatal 
brain (Moseley et al. 2003). Moreover, young hippocampal neurons have been shown to 
express all three Na+-K+ ATPase ? subunit isoforms (Cameron et al. 1994). Another note-
worthy point is that local K+ gradients are short-lived and would be expected to affect KCC2 
cotransport only slightly. Nevertheless, in view of the similarities between interaction of 
KCC2 with CKB and Na+-K+ ATPase ?2, formation of a physically linked and functionally 
coupled unit comprising KCC2, GABAAR/GlyR, CKB and Na+-K+ ATPase ?2 subunit might 
be speculated for a tight regulation of Cl- homeostasis that is required for the efficient 
inhibitory GABA/glycine signaling. A developmental regulatory mechanism might then 
replace the role played by Na+-K+ ATPase ?2 subunit by that of ?3 subunit whose expression 
dominates over that of ?2 isoform in adult neurons. Such a developmentally regulated 
transition in ?2 and ?3 mRNA expression has been observed in rat heart muscles between 
postnatal days, P7 and P14 (Orlowski and Lingrel 1988).     
Not surprisingly then, functional tyrosine-phosphorylated KCC2 has been found 
to exist in lipid rafts, functional micro-domains on the plasma membrane (Watanabe et al. 
2009). This is in consistent with studies that demonstrate localization of two key components 
of inhibitory signaling, GABAAR and Na+-K+ ATPase in lipid rafts micro-domains (Dalskov 
et al. 2005) and the role of these micro-domains in maintenance of inhibitory synapses as 
well as dendritic spines (Hering et al. 2003). However, another study has proposed that 
functional KCC2 is located in the non-raft fraction of the membrane and that the state of 
membrane-distribution is a key factor for up-regulation of KCC2 function during 
development (Hartmann et al. 2009).    
CCCs have been shown to form homo- and hetero-dimers (Blaesse et al. 2006, 
Casula et al. 2001, Gerelsaikhan and Turner 2000, Parvin et al. 2007, Pedersen et al. 2008, 
Simard et al. 2007), although the functional relevance of their oligomerization is obscure. 
Direct evidence supporting the existence of oligomeric KCC2 in native tissues came from the 
observations in rat brainstem tissue (Blaesse et al. 2006). While immature neurons harbored 
monomeric inactive KCC2, in more mature neurons, active KCC2 was shown to exist as a 
mixture  of  dimers,  trimers,  and  tetramers  (Blaesse  et  al.  2006,  but  see  Uvarov  et  al.  2009).  
Although no direct evidence was provided regarding the contribution of the oligomeric state 
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of KCC2 to its physiological function, the synchronicity between the increase in the 
proportion of oligomeric KCC2 and the activation of KCC2 function suggested changes in 
KCC2 oligomerization state might serve as a mechanism regulating maturation of 
GABAergic neurotransmission in lateral superior olive (LSO) neurons (Blaesse et al. 2006). 
Tyrosine phosphorylation of KCC2 that activated KCC2 by changing its localization to lipid 
raft domains has also been suggested to increase the oligomerized state of KCC2 (Watanabe 
et al. 2009). Recently, CIP1 (see section 1.1) was found to physically interact with KCC2 and 
activate it by heteromer formation in a heterologous expression system (Wenz et al. 2009). 
However, the mechanism of activation was not studied. 
Regulator of chromatin condensation (RCC1) domain of protein associated with 
Myc (PAM) has been demonstrated to physically interact with the C-terminal domain of 
KCC2 and increase the latter’s cotransport activity (Garbarini and Delpire 2008). The 
interaction of PAM with KCC2 was speculated to activate KCC2 by changes in KCC2 sub-
cellular localization, as a scaffolding factor for mediating interaction with other 
proteins/kinases or membrane trafficking (Garbarini and Delpire 2008). Along similar lines, a 
di-leucine motif in the C-terminus of KCC2 has been implicated in a physical interaction with 
clathrin-binding adaptor protein-2 (AP-2) that allocates the functional pool of KCC2 for a 
constitutive endocytotic recycling pathway (Zhao et al. 2008). As discussed below (section 
1.4.2), changes in the rate of insertion and/or retrieval of surface expressed KCC2 can serve 
as an important regulatory format for modulating the cotransport function of KCC2. Absence 
of an analogous di-leucine endocytotic motif in NKCC1 might serve as a useful cellular 
contrivance for differential regulation of chloride extrusion and influx mechanisms in the 
neurons (Zhao et al. 2008). 
Finally, although interaction of KCC2 and cytoskeletal associated protein 4.1N 
has been proposed to be relevant for structural development of glutamatergic synapses in 
spines (see section 1.2.2.4), it might serve a role for cytoskeletal docking of functional KCC2 
itself at inhibitory synapses on appropriate domains of the plasma membrane and/or 
regulation of its cotransport activity by direct mechanical effects of cytoskeletal elements. 
Such functional/organizational regulations are not uncommon for other ion channels and 
transporters (Bennett and Baines 2001, Denker and Barber 2002).     
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1.4.2 Regulation of KCC2 activity by changes in surface expression, trafficking 
and recycling  
Changes in activity of plasmalemmal proteins by regulation of their plasma 
membrane expression can be thought of as a strategy analogous to the regulation of cytosolic 
proteins by modulating the latter’s sub-cellular distribution and their accessibility to 
substrates. However, as in the latter case, the mere presence of a protein at the cell surface 
does not necessarily imply activity of the protein. Nevertheless, surface trafficking is clearly 
one of the initial steps of the cellular mechanism associated with functional activation of 
membrane proteins. While there is no conclusive data regarding a direct implicit kinetic 
modulation of KCC2 cotransport function and most studies on regulation of KCC2 activity 
have not distinguished between the contribution of changes in the expression of KCC2 in the 
plasma membrane and contribution of its kinetic regulation (Blaesse et al. 2009), some of the 
reports on KCC2 functional modulation have shown an apparent association of plasma 
membrane expression with its K+-Cl- cotransport function (Boulenguez et al. 2010, Lee H. H. 
et al. 2007, Rivera et al. 2004, Sarkar et al. 2011, Wake et al. 2007, Zhang L. L. et al. 2006, 
Study I).  
Developmental up-regulation of KCC2 protein causes a shift from depolarizing 
to hyperpolarizing EGABA-A in the rat hippocampus in the second week after birth (see section 
1.2.2.1). However, in many studies, the expression of total KCC2 protein has been found to 
be higher than what would be expected based upon the KCC2 functional up-regulation during 
development (Balakrishnan et al. 2003, Blaesse et al. 2006, Friauf et al. 2008, Kelsch et al. 
2001, Khirug et al. 2005, Vale et al. 2005, Zhang L. L. et al. 2006). Hence, it has been 
proposed that there is a presence of inactive KCC2 in developing neurons that requires post-
translation activation. However, these studies, by no means, belittle the essential role of 
transcriptional effects on KCC2 in mediating a developmental increase in KCC2 function, but 
indicate that there is probably enough non-functional KCC2 protein in developing neurons 
that can be activated in an allostatic manner (Sterling 2003).  
Even in juvenile (postnatal day, P19-22) rats, only a small fraction of total 
KCC2 protein (20%) is expressed in the plasma membrane of hippocampal neurons (Study 
II) at a developmental stage when hippocampal neurons have a hyperpolarizing EGABA-A 
(Khirug et al. 2005), and KCC2 mRNA (Rivera et al. 1999, Wang C. et al. 2002) and protein 
(Stein et al. 2004, Zhu L. et al. 2008, but see Dzhala et al. 2005) expression comparable to 
adult rats. In heterologous over-expression systems up to 50% of total KCC2 can be 
membrane expressed (Lee H. H. et al. 2007). The observation of presence of a small fraction 
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of surface expressed KCC2, combined with the observation that at basal levels, the 
membrane pool of KCC2 is highly dynamic (Lee H. H. et al. 2007, Rivera et al. 2004, Zhao 
et al. 2008), suggest that KCC2 function can be dynamically regulated by changes in its 
surface expression pattern by alterations in the rate of insertion and/or removal from the 
plasma membrane (Zhao et al. 2008, Lee H. H. et al. 2007, 2010). Regulation of membrane 
protein activity by retrieval and insertion into the plasma membrane seems to be a general 
cellular physiological scheme and has been implicated in synaptic plasticity both at inhibitory 
(Collingridge et al. 2004, Jacob et al. 2008, Vithlani et al. 2011) and excitatory (Collingridge 
et al. 2004, Greger and Esteban 2007, Groc and Choquet 2006) synapses.   
For KCC2, most studies have unfortunately concentrated on the changes in 
surface expression without attending to the actual mechanisms (changes in rates of insertion 
or endocytosis of surface KCC2) responsible (Blaesse et al. 2009, Chorin et al. 2011). 
However, Lee H. H. et al. (2007) did try to address the mechanism of increased surface 
expression of KCC2 mediated by protein kinase C (PKC) and showed it to be a consequence 
of a decreased rate of internalization of surface expressed KCC2 (for a similar study that has 
recently been carried out on the effects of BDNF on GABAAR in developing neurons; see 
Porcher et al. 2011). Zhao et al. (2008) have identified the critical role of a di-leucine motif in 
the C-terminus of KCC2, capable of interacting with clathrin-dependent endocytosis 
machinery via clathrin-binding adaptor protein-2 (AP-2), in the constitutive endocytosis of 
surface expressed KCC2. In contrast to Rivera et al. (2004) and Lee H. H. et al. (2010), they 
showed that the endocytosed KCC2 is not degraded by lysosomal pathway but rather is 
recycled back to the plasma membrane via a constitutive endosomal endocytotic-recylcing 
pathway (Zhao et al. 2008). However, to date, no study has addressed the relevance of 
changes in the insertion rate of KCC2 in the membrane which would be expected to have an 
inverse effect to the changes in the rate of endocytosis (see also Ortiz 2006 for NKCC2). 
Unfortunately, there are biochemical methods to quantify the re-insertion of previously 
endocytosed membrane proteins (Ehlers 2000, Porcher et al. 2011, Zhao et al. 2008) but no 
biochemical method to analyze the de novo insertion of new membrane proteins. We have 
recently developed a biochemical assay for determining the total rate of insertion of 
membrane proteins (unpublished data).     
Lastly, studies that have indicated the presence of non-functional KCC2 in 
immature neurons requiring post-translational stimulation (Balakrishnan et al. 2003, Blaesse 
et al. 2006, Kelsch et al. 2001, Khirug et al. 2005, Milenkovic et al. 2007, Zhang L. L. et al. 
2006), might point to an activation step that allows KCC2 to enter a dynamic functional pool 
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positioned in close proximity with the plasma membrane that is capable of constant recycling 
in and out of the plasma membrane. Alternatively, the activation step might allow KCC2 
already positioned near the plasma membrane to enter the dynamic recycling functional pool. 
Presence of such a low expression in the plasma membrane and a functional pool of 
membrane proteins docked in vesicles near the plasma membrane and undergoing continuous 
recycling have been observed for NKCC2 (Ortiz 2006). Hence, immunohistochemical 
techniques used to affirm surface expression of KCC2 should be used with caution since the 
resolution between actual membrane proteins and proteins in transport vesicles near the 
membrane is not optimal (see discussion in Vale et al. 2005). This also suggests requirement 
of a biochemical technique for reliable quantification of surface expressed proteins that can 
be distinguished from proteins that are not expressed on the membrane but are in close 
proximity or physically linked to the membrane components (see section 1.7 and Study II).    
 
1.4.3 Regulation of KCC2 activity by kinases and phosphatases  
There are several predicted putative phosphorylation sites for Ca2+/calmodulin-
dependent protein kinase II (CaMKII), protein kinase A (PKA), protein kinase C (PKC) and 
tyrosine  kinases  in  the  KCC2  molecule  and  most  are  located  in  the  large  intracellular  C-
terminal domain (Adragna et al. 2004, Song et al. 2002). Like other intracellular 
phosphorylation/dephosphorylation cascades that take part in rapid regulation of protein 
function, phosphorylation/dephosphorylation of KCC2 acts at the protein level in absence of 
changes in its expression pattern. Evidently, coordination of these cellular 
phosphorylation/dephosphorylation events which are critically linked to short-term regulation 
of KCC2 activity would be expected to ensure that neurons respond to different physiological 
and pathological conditions rapidly and precisely, given the critical role KCC2 plays in 
establishing and maintaining the inhibitory signaling of GABA and glycine in the CNS (see 
sections 1.2.2.1, 1.2.2.2 and 1.5). Recent studies have been directed to identify the protein 
kinases/phosphatases that are directly involved in regulation of KCC2 function. So far there 
is data confirming a direct role of tyrosine kinases/phosphatases, PKC and protein 
phosphatase 1-protein phosphatase 2A (PP1-PP2A) in regulation of KCC2 function 
(discussed below).  
Studies on regulation of KCC2 function by tyrosine kinases and particularly at 
Y1087 residue of KCC2 have produced conflicting data. Exogenous activation of a 
cytoplasmic tyrosine src kinase had been previously shown to activate KCC2 in cultured 
neurons, although no evidence for a direct KCC2 phosphorylation was provided (Kelsch et al, 
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2001). In line with this study, Y1087 has been suggested to be indispensable for surface 
expression and function of KCC2 in a heterologous system (Strange et al. 2000). Regulation 
of the tyrosine phosphorylation state of KCC2 has also been observed in models of neuronal 
stress. For instance, exposure of neurons to oxidative stress and induction of epileptic activity 
by exposure to an extracellular solution lacking Mg2+ or BDNF rapidly increased the net rate 
of tyrosine dephosphorylation of KCC2 in a Ca2+-dependent manner, which preceded a later 
phase  of  a  reduction  in  the  total  levels  of  KCC2  mRNA  and  protein.  This  fast  decrease  in  
tyrosine phosphorylation was observed concomitantly with a rapid decrease in the chloride 
extrusion capacity of KCC2 which was ascribed to a decreased surface expression of KCC2 
(Wake et al. 2007). However, the exact site of phosphorylation in the KCC2 molecule was 
not identified. Recently, phosphorylation of Y1087 has been reported to change the 
localization of plasmalemmal KCC2 in the membrane and cluster them in lipid rafts on the 
cell membrane and this change was shown to be associated with an increased KCC2 function 
(Watanabe et al. 2009). In contradiction however, Lee H. H. et al. (2010) have shown that 
phosphorylation of tyrosines at 903 and 1087 mediated by src family of tyrosine kinases 
decreases the cell surface stability of KCC2 by enhancing their lysosomal degradation in a 
pilocarpine-induced seizure model. Along similar lines, tyrosine phosphorylation has been 
implicated in neuronal injury-induced degradation of KCC2 (Shulga et al. 2012). The 
contradictory results of tyrosine kinase-mediated regulation might be explained by 
employment of different heterologous systems for KCC2 expression and/or the indirect 
modification by the kinases at different steps of cellular cascades.        
A serine at position 940 in KCC2 was proposed to be important in interaction 
with 4?-phorbol 12-myristate 13-acetate (PMA)-induced effectors, most likely, PKC and 
PKC-mediated actions were found to decrease KCC2 function (Bergeron et al. 2006). 
Henceforth, S940 was indeed shown to be a target of a dynamic phosphorylation-
dephosphorylation cycle mediated by PKC and PP1 activity, critical for functional regulation 
of KCC2 (Lee H. H. et al. 2007, 2011, Sarkar et al. 2011). However, in contradiction to 
Bergeron et al. (2006), PKC was shown to cause a functional increase of KCC2 by a direct 
phosphorylation at S940 in KCC2. The functional increase coincided with an increase in the 
surface expression of KCC2 which in turn, depended on an increased stability of KCC2 
expressed in the plasma membrane caused by a decreased internalization of surface expressed 
KCC2 (Lee H. H. et al. 2007, see also Study II). Accordingly, in an NMDA-induced model of 
neuronal  trauma,  phosphorylation  of  KCC2  at  S940  was  decreased  by  activation  of  PP1  
mediated by Ca2+ influx through NMDAR (Lee H. H. et al. 2011). This fast decrease in S940 
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phosphorylated KCC2 was concomitantly paralleled by a fast reduction in both total and 
surface protein levels of KCC2. Stress-induced decrease in KCC2 function has also been 
demonstrated to be mediated by a dephosphorylation step of S940 (Sarkar et al. 2011). In 
agreement with role of PKC phosphorylation of S940 of KCC2 in its functional up-
regulation, activation of group I metabotropic glutamate receptors (mGluR1s) has been 
shown to rapidly increase KCC2 chloride extrusion activity in a PKC-dependent manner 
(Banke and Gegelashvili 2008).  
However, consistent with the studies of Bergeron et al. (2006), another study 
has  proposed  a  PKC-mediated  rapid  down-regulation  of  KCC2  function  (Fiumelli  et  al.  
2005). Neither of these studies has specified a direct role of PKC in KCC2 phosphorylation. 
Hence, it may be possible that the PKC mediated down-regulation of KCC2 function in these 
cases were not due to a direct phosphorylation on KCC2. There are similar contradictory 
reports of PKC-mediated activation and inhibition of NKCC1 activity which have been 
proposed to be a result of indirect multistep regulation by PKC (Russell 2000). Interestingly, 
Brumback and Staley (2008) suggested that changes in Na+-K+ ATPase activity are 
responsible for activity-induced changes in EGABA-A that were observed by Fiumelli et al. 
(2005) and attributed to KCC2 (Woodin et al. 2003). Since PKC-mediated increase in KCC2 
function has been shown to involve a direct phosphorylation of KCC2 (Lee H. H. et al. 2007, 
2011, Sarkar et al. 2011), it is the most conceivable scheme concerning the direct modulation 
of KCC2 activity by PKC.   
Only one study has shown a PKA-mediated functional modulation of KCC2 
(Ouardouz and Sastry 2005). However, it fell short of describing any direct phosphorylation 
of KCC2. Surprisingly, inhibitors against both PKA and protein phosphatase could prevent 
the observed functional modulation of KCC2 (Ouardouz and Sastry 2005). 
With no lysine (WNK) kinases and their downstream Ste20-related proline-
alanine-rich-kinase/oxidative stress response kinase 1 (SPAK/OSR1) are thought to play an 
important role in controlling electrolyte homeostasis by regulation of the activity of a number 
of ion transporters, particularly the CCCs which are important regulators of cell volume 
(Delpire and Gagnon 2008, Kahle et al. 2005, 2006, MacAulay et al. 2004). There have been 
many studies on cell volume-dependent regulation of KCC2 function by WNKs but none of 
them have provided evidence for a direct phosphorylation of KCC2. Also, most of the studies 
have utilized heterologous non-neuronal systems. It is important to realize that while 
stimulation of NKCC1 activity after cell shrinkage in neurons has been documented 
(Schomberg et al. 2003), no such cell volume-mediated regulation of KCC2 activity has been 
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observed. Moreover, KCC2 expression is restricted to neurons and is thought to have a 
specific physiological function of maintaining a low [Cl-]i in isotonic conditions in neurons 
(see section 1.2.2.1). An absent (Payne et al. 1996) and modest (Song et al. 2002, Strange et 
al. 2000) activation of KCC2 cotransport function in hypotonic conditions in heterologous 
systems indicates an obscure physiological role of swelling-induced KCC2 activity in 
neurons (Williams et al. 1999, also see discussion in Song et al. 2002). While neurons are 
relatively resistant to swelling in response to osmotic changes due to absence of aquaporin 
expression, the mechanisms of cell swelling induced by hypotonia and neuronal swelling 
induced by intense activity are different (Blaesse et al. 2009, Payne et al. 2003) and hence 
data from cell volume mediated-regulation of heterologously expressed KCC2 under 
conditions of hypotonia cannot be extrapolated to physiological regulation of KCC2 function 
in situations of activity-induced neuronal swelling. Although KCC2 was proposed to limit 
dendritic swelling in response to glutamatergic excitation based upon its expression near the 
excitatory  synapses  (Gulyas  et  al.  2001),  it  was  later  shown to  be  structurally  important  for  
spine formation (see section 1.2.2.4). Indeed, while hypotonicity-induced activity of KCCs 
depends upon serine-threonine phosphatses, the constitutive isotonic activity of KCC2 was 
found to be independent of them (Mercado et al. 2006, Song et al. 2002). Hence, cell volume-
dependent modulation of KCC2 in heterologous systems may not be as relevant in the 
physiological regulation of KCC2 in the neuronal micro-environment as for other 
hypotonicity-activated KCC isoforms (Kahle et al. 2008, Mercado et al. 2004), particularly 
KCC3, which has been shown to be involved in neuronal volume regulation based upon 
knock-out studies (Boettger et al. 2003, Byun and Delpire 2007) and KCC1, based upon its 
expression in nervous system and its ability for housekeeping cell-volume regulatory function 
(Gillen et al. 1996, Kanaka et al. 2001). Interestingly, the presence of a SPAK binding motif 
and several potential threonine and serine phosphorylation sites in KCC2a but not in KCC2b 
(Uvarov et al. 2007) might indicate differential cell-volume based regulation of the two 
KCC2 isoforms.  
Nevertheless, in the context of cell volume-dependent regulation, serine-
threonine phosphorylation is thought to reciprocally increase the cotransport function of NCC 
and NKCC1-2 and decrease the transport function of KCCs (Gagnon et al. 2006, Kahle et al. 
2006, Rinehart et al. 2009, 2011). Thus, WNK3 reciprocally regulates the chloride efflux (by 
inhibition of KCC1 or KCC2) and influx (by activation of NKCC1) in neurons (Kahle et al. 
2005) and may be important in the physiology of circadian variations of GABA signaling in 
the CNS (Belenky et al. 2010, Kahle et al. 2006). WNK4 and its binding partner SPAK can 
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also  inhibit  chloride  extrusion  activity  of  KCC2,  while  reciprocally  acting  as  a  positive  
regulator of NKCC1 function (Gagnon et al. 2006, Garzon-Muvdi et al. 2007). Recently, 
WNK2-mediated phosphorylation has been implicated in decreasing KCC2 function and 
increasing NKCC1 function (Rinehart et al. 2011). Although the authors showed an abundant 
WNK2 expression in the brain, the indirect evidence for KCC2 modulation relies on studies 
in Xenopus heterologous expression system. Interesting, while WNK2 phosphorylation 
caused an increased surface expression of NKCC1, changes in KCC2 surface expression 
were not addressed (Rinehart et al. 2011). Rinehart et al. (2009) have identified two 
phosphorylation sites which are conserved among all KCC isoforms and can be modulated 
during development and by physiological perturbations and contribute to functional 
regulation of KCCs. Thus, KCC3 was found to be dephosphorylated at T991 and T1048 in 
response to hypotonicity and this caused a cooperative activation of KCC3. The homologous 
threonine phosphorylation sites in KCC2, T906 and T1006, were shown to be 
developmentally regulated i.e. neonatal brain had phosphorylated KCC2 while the adult brain 
lacked it. Based upon the finding that phosphorylation states of in KCC3 is sensitive to 
WNK1 and PP1 and PP2A and leads to modulation of the intrinsic transport function of 
KCC3 without affecting the surface expression, cotransport function of KCC2 was proposed 
to  be  regulated  in  an  analogous  manner.  However,  direct  involvement  of  any  kinase  or  
phosphatase in regulation of the phosphorylation status of T906 and T1006 in KCC2 was not 
addressed (Rinehart et al. 2009).       
There is some indirect evidence that KCC2 function is positively regulated by 
PP1-PP2A under hypotonic conditions. This is based upon data that inhibition of PP1-PP2A 
abolishes swelling-induced chloride extrusion activity of KCC2 but does not seem to have 
any effect on the constitutive chloride extrusion function of KCC2 (Mercado et al. 2006). But 
other reports suggest that protein phosphatases can induce changes in KCC2 function in 
isotonic conditions. Hence, unhindered activity of PP1-PP2B by expression of inactive forms 
of WNK4 kinase was suggested to increase KCC2 activity in isotonic conditions (Garzon-
Muvdi et al. 2007). Recently,  NMDA  and  Ca2+ induced  activation  of  PP1  was  shown  to  
dephosphorylate S940 residue in KCC2 in the glutamate excitotoxicty model of trauma (Lee 
H. H. et al. 2011). Thus while PKC mediated phosphorylation increased the surface stability 
of KCC2 (Lee H. H. et al. 2007), PP1-mediated dephosphorylation decreases surface stability 
of  KCC2  which  is  ultimately  degraded  (Lee  H.  H.  et  al.  2011).  However,  the  how  
dephosphorylation of S940 leads to degradation of KCC2 protein was not demonstrated.  
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In conclusion, it seems likely that KCC2 function is dynamically regulated by a 
differential activation of specific protein kinases and phophatases in distinct neuron types and 
under distinct conditions. 
 
1.4.4 Regulation of KCC2 activity by protein degradation  
As previously described, KCC2 expression levels show an activity-dependent 
decrease in various pathological and physiological conditions (see section 1.2.2.2). Although 
there are observations of degradation of KCC2 at both mRNA and/or protein levels in these 
studies, the relative contributions of transcriptional, post-transcriptional and post-translational 
regulations of KCC2 function have remained obscure. Recent studies have advocated for 
post-translational regulation of KCC2 function (including protein degradation) that could 
account for the fast decrease in many of these models (Fiumelli et al. 2005, Lee H. H. et al. 
2011, Wake et al. 2007, Study III), suggesting that regulation of KCC2 at the level of 
translation takes effect only at a later stage. Moreover, there seem to be two phases of 
functional decrease of KCC2 at the protein level – an initial rapid phase that might involve 
reduced surface expression of KCC2 followed by a delayed and sustained phase that most 
probably involves protein degradation (Kitamura et al. 2008, Lee H. H. et al. 2011, Wake et 
al. 2007, Wardle and Poo 2003) that might consolidate the initial effect.  
Some studies suggested a fast degradation of surface expressed and total KCC2 
under basal conditions (Lee H. H. et al. 2010, Rivera et al. 2004). Hence, it was thought that 
the decrease in KCC2 protein amount was an indirect effect of KCC2 mRNA degradation. 
However, using experimental blockade of both protein synthesis as well as protein 
degradation, we show that in brain slice preparations, KCC2 protein is much more stable than 
previously thought (Study III). This seems a bit surprising since unlike other KCCs, KCC2 C-
terminal domain harbors two predicted PEST (proline/glutamate/serine/threonine) sequences 
(Mercado et al. 2006) which are thought to signal degradation of a protein. However, as 
opposed  to  an  active  PEST  domain,  PEST  domains  that  are  latent  can  serve  as  signals  for  
regulated degradation of proteins (Rechsteiner and Rogers 1996, Rogers et al. 1986). This 
suggests that PEST sequences in KCC2 might be latent and activated in pathophysiological 
conditions by post-translational modifications like phosphorylation/dephosphorylation for its 
lysosomal degradation (Lee H. H. et al. 2010).  
Interestingly, a number of studies have implicated Ca2+ influx through activated 
NMDAR in activity-dependent decrease of KCC2 expression/function (Kitamura et al. 2008, 
Lee H. H. et al. 2011, Liu Y. et al. 2009, Wang W. et al. 2006). In Study III, we have shown 
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that KCC2 can indeed be down-regulated by calpain-mediated proteolysis (see next section). 
In summary, proteolysis/degradation of KCC2 protein by calpain or lysosomal activity might 
function as a fast mechanism of changing neuronal chloride homeostasis in various 
physiological and pathophysiological states. 
 
1.4.4.1  Calpain and KCC2 
Calpains are calcium-activated cysteine endoproteases that act at neutral pH 
(Croall and DeMartino 1991, Goll et al. 2003, Saido et al. 1994). Out of a dozen, two calpain 
isoforms – calpain-1 (?-calpain) and calpain-2 (m-calpain) are abundantly expressed in 
neurons and localize in both soma and synaptic terminals (Liu J. et al. 2008a, Zadran et al. 
2010a). While calpain-1 requires 1-20 ?M Ca2+ for activation, calpain-2 needs Ca2+ in mM 
concentration ranges for activation in vitro (Goll et al. 2003, Liu J. et al. 2008a, Zadran et al. 
2010a). Since an increase of [Ca2+]i concentration to ?M ranges is associated with conditions 
of hyperexcitability because of opening of glutamate and voltage gated calcium channels, 
calpain-1 has been shown to be activated in response to excessive exposure to glutamate or 
agonists of glutamatergic receptors. Interestingly, interaction of both calpains with 
phospholipids in sub-membrane cellular regions can decrease the calcium requirement for 
activation (Chakrabarti et al. 1996, Saido et al. 1994, Shao et al. 2006) and might result in 
their localized and short activation. Indeed, controlled activation of calpain-1 and 2 by 
interaction with phospholipids in a sub-membrane microenvironment near the source of 
calcium influx might explain why many calpain substrates are membrane expressed or 
associated proteins and might be critical for calpain-mediated regulation of synaptic signaling 
of neuronal networks (Liu J. et al. 2008a). Recently, calpain-2 has been shown to be activated 
by BDNF-TrkB-MAPK signaling independent of [Ca2+]i (Zadran et al. 2010b).   
Calpains have been implicated in regulation of widespread neuronal functions 
like neural development and gene transcription; synaptic plasticity and structural stability of 
synapses; neurotransmitter release and vesicular trafficking (Goll et al. 2003, Liu J. et al. 
2008a, 2008b, Lynch G. and Baudry 1984, Shiosaka 2004, Tomimatsu et al. 2002, 
Vanderklish et al. 1995, Wu H. Y. and Lynch 2006, Zadran et al. 2010a, 2010b). 
Interestingly, calcium overload-induced unregulated and hyperactive calpain-mediated 
proteolysis has been proposed to contribute to the mechanisms of neuronal death (Liu J. et al. 
2008a, Wu H. Y. and Lynch 2006) observed in models of excitotoxicity (Bano et al. 2005, 
Liu J. et al. 2008b, Siman and Noszek 1988, Siman et al. 1989, Xu et al. 2007), and 
pathogenesis of excitotoxicity-related pathologies like ischemic (Bartus et al. 1994, 1995, 
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Bevers and Neumar 2008, Lee K. S. et al. 1991, Schafer et al. 2009) and traumatic brain 
injuries (Kampfl et al. 1997, Pike et al. 2001, Posmantur et al. 1997), seizures (Araujo et al. 
2008, Bi et al. 1996a, 1997, Feng et al. 2011, Holopainen 2008, Xu et al. 2007) and 
neurodegenerative diseases like Alzheimer’s disease (Lee M. S. et al. 2000, Liu F. et al. 2005, 
Raynaud and Marcilhac 2006, Saito et al. 1993). However, several reports suggest that 
calpain might have complex roles aiding both toxic and protective aspects of pathophysiology 
of neurodegeneration, probably depending on the kind, severity and stage of insult (Faddis et 
al. 1997, Lynch D. R. and Gleichman 2007, Neumar et al. 2003, Pike et al. 1998, Wang K. K. 
2000, Wu H. Y. and Lynch 2006).  
As a regulatory protease, not surprisingly, only a relatively small number of 
proteins have been identified as substrates for calpain. These include cytoskeletal proteins, 
transcription factors, membrane receptors, ion channels, and transporters (Goll et al. 2003, 
Liu J. et al. 2008a, Lynch D. R. and Gleichman 2007). Moreover, calpain-cleavage results in 
limited fragmentation of proteins even under in vitro conditions (Goll et al. 2003, Saido et al. 
1994). Calpain-mediated fragmentation can either modulate, activate or abolish the substrate 
protein’s original function (Kishimoto et al. 1989, Saido et al. 1994) or the fragments 
generated  might  acquire  novel  functions  such  as  regulation  of  gene  transcription  (Lynch D.  
R. and Gleichman 2007).  
Of the various physiological processes regulated by calpain, particularly 
interesting are those involved in maintenance and plasticity of synaptic signaling. Calpain 
proteolyzes and regulates the function of proteins involved in structural, functional and 
regulatory aspects of glutamatergic synaptic signaling. Hence, cytoskeletal and associated 
proteins like spectrin (Seubert et al. 1989, Siman et al. 1984), ankyrin-rich membrane 
spanning protein (ARMS) (Wu S. H. et al. 2010), microtubule associated protein (MAP) 
(Sandoval and Weber 1978, Siman and Noszek 1988) as well as proteins that function as ion 
channels and as mediators of intracellular signaling in response to extracellular cues like 
NMDAR (Bi et al. 1998b, Guttmann et al. 2001), AMPAR (Bi et al. 1998a, 1996b) and 
mGluR subunits (Xu et al. 2007), and their anchoring proteins like glutamate receptor-
interacting protein (GRIP) (Lu X. et al. 2001) and postsynaptic density protein-95 (PSD-95) 
(Lu X. et al. 2000) have been shown to be calpain targets. In addition, kinases and 
phosphatses like PKC (Kishimoto et al. 1989), calmodulin-dependent protein kinase II 
(CamKII) (Hajimohammadreza et al. 1997) and calcineurin (Liu F. et al. 2005) that can 
modify glutamatergic signaling are also cleaved by calpain. Evidently, previous studies have 
concentrated on the effects of calpain activation on excitatory glutamatergic synaptic 
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signaling. Only recently have studies shown that calpain can also regulate synaptic signaling 
at GABAergic synapses by modulation of the presynaptic (Gomes J. R. et al. 2011) as well as 
postsynaptic (Kawasaki et al. 1997) machineries. Hence, a vesicular GABA transporter 
(VGAT)  was  shown  to  be  a  calpain  substrate  in  models  of  ischemic  injury,  glutamate-
excitotoxicity and seizure-like activity (Gomes J. R. et al. 2011). Similarly, glycine 
transporter 2 (GlyT2) has also been shown to be a calpain substrate (Baliova et al. 2004). 
Gephyrin, a critical scaffolding protein for the postsynaptic GABAAR clustering (Jacob et al. 
2005, Tyagarajan and Fritschy 2010) was shown to be regulated by calpain-mediated 
cleavage (Kawasaki et al. 1997). In Study III, we have shown that KCC2 is a target of calpain 
proteolysis in vitro as well as in models of excitotoxicity and seizure-like activity. 
Interestingly, calpain cleavage of KCC2 in vitro does not seem to require the presence of its 
PEST domains (unpublished data). This is not surprising since the absolute requirement of 
PEST domains in calpain-mediated degradation of PEST-containing proteins is obscure 
(Carillo et al. 1996, Rechsteiner and Rogers 1996, Tompa et al. 2004). Indeed, calpain-
recognition seems to require disordered secondary and tertiary structural determinants rather 
than the primary structure of proteins alone (Stabach et al. 1997, Tompa et al. 2004). 
Alternatively, the latent PEST domains in KCC2 might be activated by phosphorylation/de-
phosphorylation of nearby residues (Lee H. H. et al. 2011) for recognition by calpain.       
Since KCC2 is a protein that has an important functional role in GABAergic 
signaling as well as a structural role in glutamatergic signaling (see sections 1.2.2.1 and 
1.2.2.4), the observation that KCC2 is a calpain target (Study III) has physiological 
consequences for both inhibitory and excitatory signaling in the neuronal networks. 
Importantly, calpain cleaves KCC2 in the C-terminal region (unpublished data) that has been 
shown to interact with protein 4.1N which is critically important in cytoskeletal organization 
at synapses (see section 1.2.2.4). Moreover, as stated above, calpain-2 can be activated by 
BDNF-TrkB-MAPK signaling in neurons and rearrangements in the actin cytoskeletal at 
synapses by BDNF-calpain signaling (Bramham 2008, Glading et al. 2004, Zadran et al. 
2010b) might employ proteolysis of KCC2 and modulation of its structural role as one of the 
strategies.  The  link  between calpain  and  KCC2 might  also  be  speculated  to  serve  as  one  of  
the mechanisms employed by BDNF in regulation of KCC2 function and hence regulation of 
synaptic signaling at inhibitory synapses under pathophysiological conditions (see sections 
1.2.2.2, 1.3.2 and 1.5).  
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Fig.2. Known post-translational mechanisms affecting KCC2 cotransport. 
A number of mechanisms can regulate KCC2 function including protein-protein interactions, 
phosphorylation as well as protein degradation. The mechanisms have been described in 
detail in the text. The key for the various molecules used is shown on the left. Open arrow 
denotes a reduced rate of retrieval from the membrane. The numbers in the figure represent 
the  citations  from  which  the  data  is  derived  from.  These  are  as  follows-1:  Ikeda  K.  et  al.  
2004, 2: Blaesse et al. 2006, 3: Huang Y. et al. 2012, 4: Gulyas et al. 2001, 5: Inoue et al. 
2006, 6: Zhao et al. 2008, 7: Lee H. H. et al. 2007, 8: Study II, 9: Study III, 10: Lee H. H. et 
al. 2010.  
 
1.5 Activity-dependent regulation of KCC2 in developmental and 
pathophysiological regulation of Cl-  
Some parts of this section have been discussed elsewhere in this thesis, but have 
been included here to summarize the topic. Several studies have shown an activity-dependent 
modulation of KCC2 function/expression and the consequent changes in inhibitory 
neurotransmission mediated by GABAAR signaling which may have a profound effect on the 
overall synaptic homeostasis (Fiumelli and Woodin 2007). Interestingly, the changes in 
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KCC2 function mediated by activity seem to be dependent on the developmental status of the 
neurons (Wright et al. 2011).  
Depolarizing actions of GABA (and glycine) in immature neurons have been 
proposed to induce KCC2 expression in a Ca2+-dependent manner and accelerate the 
developmental shift in GABA signaling from depolarizing to hyperpolarizing (Bray and 
Mynlieff 2009, Galanopoulou and Moshe 2003, Galanopoulou et al. 2003, Ganguly et al. 
2001, Leitch et al. 2005, Shibata et al. 2004). Interestingly, the shift in GABAergic signaling 
paralleled by an up-regulated KCC2 expression was accelerated by maternal separation as 
well as recurrent seizures in immature male rats and was GABAAR-dependent (Galanopoulou 
2008c). Even a single episode of status epilepticus can rapidly increase the functional 
expression of KCC2 in the plasma membrane without changing its protein levels (Study I). 
However, other studies have demonstrated a lack of effect of GABA mediated depolarizing 
synaptic transmission on KCC2 developmental up-regulation (Ludwig et al. 2003, Pfeffer et 
al. 2009, Titz et al. 2003, Wojcik et al. 2006). The importance of compensatory changes in 
maintaining synaptic homeostasis (Kilman et al. 2002, Liu G. 2004, Marty S. et al. 2002, 
Mody 2005, Turrigiano and Nelson 2004, Tyagarajan and Fritschy 2010, Wang D. D. and 
Kriegstein 2008, 2011) should not be ignored after disallowing GABA-mediated 
depolarization and subsequent Ca2+ transients in immature neurons. Indeed, knocking out or 
pharmacological block of NKCC1 that causes a block of GABAergic depolarization, leads to 
an increased excitability of glutamatergic signaling and has little effect on KCC2 
developmental up-regulation (Sipila et al. 2009). KCC2 up-regulation may require only sub-
threshold membrane depolarization that is sufficient to open low-threshold L-type VGCCs 
and cause an increase in [Ca2+]i (Bray and Mynlieff 2009, Fiumelli and Woodin 2007).  
There are reports that have implicated excitatory glutamatergic inputs in the 
developmental up-regulation of KCC2 in immature neurons  (Kanold and Shatz 2006, Liu Y. 
et al. 2009, Shibata et al. 2004, but see Ganguly et al. 2001, Ludwig et al. 2003, Titz et al. 
2003). In addition to synaptic activation of glutamatergic ionotropic receptors and the 
consequent depolarization ensued by it, activation of group I metabotropic glutamatergic 
receptors (mGluR1s) have also been shown to rapidly up-regulate KCC2 function in a PKC-
dependent manner (Banke and Gegelashvili 2008). Recently, vesicular Zn2+ which is released 
along with glutamate has been demonstrated to increase the surface expression and activity of 
KCC2 via metabotropic zinc-sensing receptor (mZnR) in a Ca2+-dependent manner in 
hippocampus of juvenile (P12-15) mice (Chorin et al. 2011). Spontaneous nicotinic 
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cholinergic activity has also been suggested to up-regulate KCC2 during development and 
contribute to the shift in GABA signaling (Liu Z. et al. 2006).  
Another approach to test whether neuronal activation promotes maturation of 
inhibitory GABAergic transmission via an up-regulation in KCC2 function/expression is by 
studying the effects of sensory deprivation on the GABAergic shift. Cochlear ablations prior 
to onset of hearing (Shibata et al. 2004), rearing of turtles in dark (Sernagor et al. 2003) and 
removal of synaptic inputs from the brainstem by spinal cord-transection (Jean-Xavier et al. 
2006) have all been shown to prevent the developmental GABA switch in the respective 
sensory centers.       
Whether or not GABA is required for its own depolarizing to hyperpolarizing 
shift and whether direct effects of depolarizing GABA or a consequent downstream action of 
neurotrophins (see below) is the actual trigger is debatable, especially considering that 
blocking GABA depolarization in immature neurons only delays the GABAergic switch and 
does not abolish it. However, what is certain is that sources of depolarization in the immature 
neurons do play an important role in maturation of inhibitory neurotransmission (Gaiarsa 
2004, Gubellini et al. 2001), in part by postsynaptic mechanisms of an increase in KCC2 
expression/function (Fiumelli and Woodin 2007, Shibata et al. 2004). However, since 
depolarization-induced Ca2+ transients (Katz and Shatz 1996) as well as neurotrophic factors 
(Gottmann et al. 2009) affect almost all developmental programs in neurons, it is difficult to 
examine whether their effect on the up-regulation of KCC2 function/expression is direct and 
specific.      
Nevertheless, neurotrophic factors, in particular, BDNF have been suggested to 
play a critical role in developmental KCC2 up-regulation (see section 1.3.2). BDNF shows an 
increased activity-dependent synthesis and release by GABA mediated depolarization in a 
Ca2+-dependent manner in developing neurons (Berninger et al. 1995, Marty S. et al. 1996, 
Porcher et al. 2011) but a reduced release by hyperpolarizing GABA transmission in more 
mature neurons (Berninger et al. 1995, Obrietan et al. 2002, Porcher et al. 2011). Since 
kainate-induced seizures have been shown to increase the expression of BDNF in developing 
rats (Kornblum et al. 1997, Yokoi et al. 2007), the kainate-induced increase in the total 
(Galanopoulou 2008c) and plasma membrane expressed (Study I) protein levels of KCC2 
might be mediated by BDNF-TrkB signaling (unpublished data). However in mature neurons, 
BDNF depresses KCC2 expression/function (see above). This is somewhat similar to the 
proposed  age-specific  effects  of  GABA  on  KCC2  expression.  While  GABAAR agonists 
increase the expression of KCC2 in immature (male) neurons of substantia nigra that exhibit 
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depolarizing GABA currents, they decrease KCC2 expression in (female) substantia nigra 
neurons that already have hyperpolarizing GABA responses at a similar age (Galanopoulou 
2007, 2008c, Galanopoulou and Moshe 2003, Galanopoulou et al. 2003).   
In mature neuronal networks, activity-dependent mechanisms reduce 
GABAergic inhibitory responses in physiological and pathophysiological states by 
depressing KCC2 function/expression (see section 1.2.2.2). Periods of high frequency activity 
like postsynaptic spiking alone (Fiumelli et al. 2005) or coupled with GABAergic 
transmission (Balena et al. 2010, Ormond and Woodin 2011, Woodin et al. 2003) can lead to 
fast reduction in KCC2 function in Ca2+-dependent manner, most likely by changes in its 
surface expression which is manifested as a decrease in inhibitory GABA signaling (Fiumelli 
et al. 2005, Woodin et al. 2003).  
In addition to spiking activity, glutamatergic activity regulates [Cl-]i by changes 
in expression/function of KCC2 and thus contributes to efficiency of inhibitory GABAergic 
signaling. Hence, induction of long term potentiation (LTP) in hippocampal neurons (Liu Y. 
et al. 2009) and application of glutamate or repetitive activation of glutamatergic neurons 
(Kitamura et al. 2008) have been shown to induce a decrease in KCC2 expression and 
function in an NMDA-dependent Ca2+-mediated manner. In pathological glutamate 
excitotoxicity (Lee H. H. et al. 2011, Study III) and during seizures (see section 1.2.2.2), 
KCC2 function undergoes a fast decrease.  
As stated above, neurotrophins like BDNF have also been proposed to decrease 
KCC2 expression and function in mature neuronal networks in an activity-dependent manner 
in physiological and pathophysiological conditions (Boulenguez et al. 2010, Coull et al. 2005, 
Huang Y. et al. 2012, Mao et al. 2011, Miletic and Miletic 2008, Molinaro et al. 2008, Rivera 
et al. 2002, 2004, Wake et al. 2007, Wardle and Poo 2003, Zhang W. et al. 2008). Since 
BDNF in mature neurons has been shown to be released in an depolarization-dependent Ca2+-
mediated manner (Binder and Scharfman 2004, Gottmann et al. 2009, Kovalchuk et al. 2004, 
Kuczewski et al. 2009), pathophysiological neuronal hyperactivity might decrease KCC2 
expression/function indirectly via BDNF activation of TrkB (Mao et al. 2011, Rivera et al. 
2004, Wake et al. 2007, Wardle and Poo 2003). Similar to its age-dependent action on KCC2 
expression/function, BDNF potentiates depolarizing GABAergic signaling in immature 
neuronal networks but suppresses hyperpolarizing signaling in mature ones (Brunig et al. 
2001, Mizoguchi et al. 2003, Porcher et al. 2011). Recently, it has been proposed that BDNF 
can potentiate the inhibitory GABAergic responses only in the absence of KCC2 and in 
conditions of high [Cl-]i (Huang Y. et al. 2012). Interestingly, the reappearance of KCC2 after 
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neuronal trauma has also been shown to depend on BDNF-TrkB-mediated signaling, 
reminiscent of the developmental up-regulation of KCC2 (Boulenguez et al. 2010, Shulga et 
al. 2008, 2012). Hence, BDNF signaling may be a common regulatory mechanism for a 
functional decrease of KCC2 during aberrant neural activity (Wright et al. 2011).              
 
1.6 Neonatal seizures and KCC2 
Various lines of evidence have correlated epilepsy with an altered chloride 
homeostasis. KCC2 down-regulation and the associated decrease of GABAergic inhibition 
(or  increase  of  GABAergic  excitation)  has  been  implicated  in  the  pathogenesis  of  seizures  
(Kahle et al. 2008, Payne et al. 2003). In addition, deficiency of KCC2 leads to increased 
propensity to hyperexcitability and seizure-like activity (Hekmat-Scafe et al. 2006, Hubner et 
al. 2001, Khalilov et al. 2011, Riekki et al. 2008, Stil et al. 2011, Tornberg et al. 2005, 2007, 
Woo et al. 2002, Zhu L. et al. 2008). Both in vitro and in vivo epilepsy models in rodents and 
human epileptic tissue have a reduced KCC2 expression associated with an impaired 
GABAergic inhibition (see section 1.2.2.2). However, it is not really clear if this down-
regulation is actually a consequence or a cause of epilepsy i.e. whether it is the primary event 
contributing to seizure pathogenesis or a secondary event that is a seizure-suppressive 
mechanism (Kahle et al. 2008, Miles et al. 2012).  
Depolarizing GABA responses in immature neurons are due to a higher [Cl-]i in 
presence of a robust NKCC1-mediated chloride influx and absence of KCC2-mediated 
chloride extrusion (see section 1.2.2.1). Since GABA acts as the major inhibitory drive in the 
nervous system, depolarizing actions of GABA result in a suppressed inhibition of neuronal 
circuits and at the same time can cause their excessive excitation via membrane 
depolarization. Consequently, pathogenesis of neonatal seizures is different from seizures in 
the adult animals and depolarizing GABAergic signaling is thought to aid the generation of 
seizures in the developing brain (Ben-Ari 2006, Ben-Ari and Holmes 2005, 2006, Briggs and 
Galanopoulou 2011, Dzhala and Staley 2003, Dzhala et al. 2010, Galanopoulou 2008b, 
Galanopoulou and Moshe 2009, Glykys et al. 2009, Kahle and Staley 2008, Khalilov et al. 
2005, Khazipov et al. 2004, Nardou et al. 2011).  
However, as previously stated, both depolarizing and hyperpolarizing GABAAR 
currents can act as inhibitory signals by shunting membrane conductance, GABAAR 
activation that mediates depolarizing currents can either be excitatory or inhibitory in 
developing neurons (see section 1.2.2.1). Moreover, immature hippocampal neurons have a 
wide variation in [Cl-]i depending  on  cell  type  and  size  and  hence  differential  responses  to  
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GABA signaling are possible depending on whether GABAAR Cl- fluxes are directed 
inwardly or outwardly (Dzhala et al. 2010, Tyzio et al. 2007). Hence, there are several 
contradictory  reports  of  pro-convulsant  and  anti-convulsant  effects  of  GABAergic  signaling  
in developing animals (Ben-Ari et al. 2007, see also Table 1 in Dzhala et al. 2010) . An 
analogous  effect  of  GABAAR agonists in protective vs aggravating effect for immature vs. 
mature neurons on ischemia- and excitotoxicity-induced neuronal injury has also been 
underlined (Schwartz-Bloom and Sah 2001).  
Pharmacological enhancement of GABAAR  currents  that  has  been  used  as  a  
strategy to subdue seizures in adults have often been found to be ineffective to a large extent 
in controlling seizures in neonates and can even potentiate them especially recurrent seizures 
that progressively increase [Cl-]i in  absence  of  a  robust  Cl- extrusion mechanism in the 
immature neurons (Briggs and Galanopoulou 2011, Dzhala et al. 2005, 2008, 2010, Glykys et 
al. 2009, Kahle and Staley 2008). Consequently, antagonists against NKCC1-mediated 
chloride influx that ultimately reduce the depolarizing drive of GABAAR activation have 
been shown to reduce neonatal seizures both alone and in conjugation with GABAAR 
agonists (Briggs and Galanopoulou 2011, Dzhala et al. 2005, 2008, 2010, Glykys et al. 2009, 
Kahle and Staley 2008, Mazarati et al. 2009, Nardou et al. 2009, 2011). However, other 
studies have suggested that cotransport function of NKCC1 prevents hyperexcitability of 
immature neuronal circuits and pharmacological blockade of NKCC1 function results in 
hyperexcitability and increased risk of seizure pathogenesis (Kilb et al. 2007, Zhu L. et al. 
2008).  
Little is known how KCC2 cotransport function is modulated during seizure 
episodes in developing neurons and what consequences this has on its pathogenesis. 
Recurrent seizures shift the GABA signaling from hyperpolarizing to depolarizing in 
developing (female) neurons, which attain hyperpolarizing GABAergic signaling much 
before male pups (Galanopoulou 2008c). Interestingly, recurrent seizure episodes in 
immature (male) neurons with depolarizing GABAergic responses of identical age resulted in 
an up-regulated KCC2 expression and a shift in GABAergic signaling to hyperpolarization 
(Galanopoulou 2008c). Thus, translational effects of recurrent seizures on KCC2 function are 
different in neurons with hyperpolarizing and in those with depolarizing GABAergic 
responses (Galanopoulou 2007). In addition to this expressional increase of KCC2 that causes 
a depolarizing shift in GABA signaling in immature (male) neurons after triple seizure 
episodes, we have shown that a short episode of seizure is sufficient to rapidly increase the 
activity of KCC2 by inducing changes in its plasma membrane expression levels without 
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changing its total expression levels in immature (male) neurons (Study I). This fast and 
transient post-translational effect on KCC2 function is abolished by kinase inhibitor K252a 
(Study I) and is mediated by BDNF-TrkB signaling (unpublished data). Such an increase in 
KCC2 function by post-translational mechanisms in developing neurons has also been 
proposed to explain the regulation of KCC2 function by thyroid hormones (Friauf et al. 
2008). Since, depolarizing GABAAR have been implicated in generation of seizures in the 
neonatal rat hippocampus, a fast increase in KCC2 plasma membrane expression and K+-Cl- 
cotransport can act as a protective mechanism against ictogenesis in neonatal hippocampus 
and may explain the resistance of developing animals to seizure-induced cell loss and 
subsequent seizures (Ben-Ari and Holmes 2006, Galanopoulou 2007, Galanopoulou and 
Moshe 2009, Galanopoulou et al. 2002, Holopainen 2008, Scantlebury et al. 2007).       
Although Study I deals with regulation of KCC2 function in a model of 
neonatal seizure, the observations made throw some light on activity-mediated post-
translational regulation of KCC2 function in general. A number of studies have proposed the 
existence of non-functional KCC2 protein in immature neurons, the activation of which being 
dependent on diverse signals like changes in phosphorylation states and/or indirect effects 
mediated by protein kinases (Balakrishnan et al. 2003, Fiumelli et al. 2005, Kelsch et al. 
2001, Khirug et al. 2005, Vale et al. 2005, Woodin et al. 2003, but see Stein et al. 2004), 
oligomerization (Blaesse et al. 2006), plasma membrane expression (Gulyas et al. 2001, 
Zhang L. L. et al. 2006) and localization in non-raft domains (Hartmann et al. 2009). Since 
exogenous over-expression of KCC2 in immature neurons has been shown to result in 
hyperpolarizing GABA responses (Chudotvorova et al. 2005, Lee H. et al. 2005), the 
mechanisms of KCC2 post-translational modification and trafficking thought to activate 
KCC2 function during maturation would be expected to be present in the developing neurons 
before the endogenous up-regulation of KCC2 function. This is consistent with the finding 
that kinetics of developmental KCC2 up-regulation are different in slices and cultures and 
KCC2 can be rapidly activated by a global kinase inhibition in immature cultures but not in 
immature slices (Khirug et al. 2005), implying that in vivo KCC2 molecules are already 
phosphorylated (for comparison of tyrosine phosphorylation status of KCC2 during 
development in cultures and in vivo, refer to Kelsch et al. 2001 and Stein et al. 2004). Hence, 
it seems likely that even when only a small fraction of KCC2 is actually surface expressed 
(Study II), the immature neurons have enough KCC2 that can be activated via post-
translational mechanisms for a rapid increase in the chloride extrusion capacity comparable to 
mature neurons (Study I).    
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1.7 Biochemical techniques to quantitate surface expressed protein  
As discussed previously, for most cell-surface active proteins including 
transporters like KCC2, regulation of their surface expression serves as an important 
modulator of their function (see section 1.4.2). Hence, biochemical analysis of absolute and 
relative surface expressed proteins is a relevant area of interest for membrane protein 
biochemists. The traditional method of quantifying proteins expressed on the plasma 
membrane has been centrifugation-based sub-cellular fractionation (Heynen et al. 2000, Jones 
and Matus 1974, Nielsen et al. 2005, Wolfe et al. 1971). It has however, lost much of its 
significance since it results in preparations of crude plasma membrane fractions that are 
almost always cross-contaminated with intracellular membranes (Huber et al. 2003, Lund et 
al. 2009).  
For long, biotinylation has served as the method of choice for quantitative 
analysis of surface expressed proteins for cells in suspension (Elia 2008, Luna 2001, 
Wisniewski 2011) and also for brain slice preparations (Gutlerner et al. 2002, Heynen et al. 
2003, Thomas-Crusells et al. 2003). The technique relies on covalent labeling of proteins in 
the plasma membrane by membrane-impermeant chemically-modified biotin (vitamin H) 
derivatives. Although depending upon the conjugated functional group, biotin derivatives can 
also be covalently linked to carbohydrate moieties and thiol groups in a protein (Elia 2008, 
Luna 2001), the most commonly used derivatives of biotin for surface labeling are N-
hydroxysucciniimide (NHS) esters that label surface expressed proteins at the primary amino 
groups of lysyl residues on accessible extracellular sites at physiological pH in solutions 
lacking primary amines (Luna 2001). Subsequently, biotin-labeled proteins that represent the 
surface expressed proteins can be purified by utilizing the extremely sturdy non-covalent 
interaction between biotin and avidin/streptavidin (Green 1975, Wilchek and Bayer 1990). 
However, there are several drawbacks of this technique. The purification step for biotin-
labeled proteins can be both time consuming as well as error-prone. Absolute quantification 
of the ratio of the plasma membrane pool of the protein of interest by Western blotting 
requires loading the biotinylated and internal proteins on different lanes (Boudreau and Wolf 
2005) and is complicated because of an absence of a single protein that can serve as a loading 
control for both the biotinylated and the internal protein fractions (Study II). Another 
potentially problematic complication is the contamination of labeled surface expressed 
protein fraction after biotinylation of intact cells with cytoplasmic proteins; mainly those 
involved in cell signaling, cytoskeletal organization and vesicular trafficking (Scheurer et al. 
2005, Yu et al. 2006), probably because of their strong association with membrane proteins 
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which persists even in presence of strong detergents used in solubilizing membrane proteins. 
The problem of contamination might also be aggravated by non-existence of an idealized 
membrane-impermeable characteristic of common commercial biotin reagents even at low 
temperatures (Peirce et al. 2004, Yu et al. 2006) which may be due to presence of a plasma 
membrane receptor for biotin (Vesely et al. 1987). In addition, presence of an endogenous 
biotinidase that can catalyse both removal of attached biotin and its transfer to another 
molecule, is another potentially detrimental factor in using biotin to characterize the surface 
expression of proteins (Hymes and Wolf 2000).   
Another method that employs covalent modification of surface expressed 
proteins utilizes a membrane-impermeant reactive molecule bis(sulfosuccinimidyl) suberate 
(BS3) (Mattson et al. 1993, Staros 1982). BS3 is a primary amine reactive homo-bifunctional 
cross-linker that can form covalent amides with lysyl residues of proteins at physiological pH 
and in aqueous solutions lacking primary amines (Staros 1982). It has been used for 
quantification of surface expressed proteins both in cell cultures (Archibald et al. 1998, Hall 
and Soderling 1997a, 1997b, Hall et al. 1997) and in brain slices (Boudreau and Wolf 2005, 
Boudreau et al. 2007, Grosshans et al. 2002a, 2002b). However, BS3 cross-linking of surface 
proteins can lead to formation of excessively high molecular weight covalent complexes 
which do not reliably enter polyacrylamide gels and resolve properly and hence are difficult 
to quantitate (Grosshans et al. 2002b, Liang et al. 2007). Hall and Soderling (1997b) have 
suggested a shortened reaction time for BS3 cross-linking as a solution to limit the excessive 
covalent cross-linking, but this could lead to a reduced efficiency of the reaction.   
Finally, molecular shaving of cell surface by use of proteases like trypsin and 
chymotrypsin has also been employed for quantitative analysis of the surface pool of 
membrane proteins in cell cultures (Hall and Soderling 1997a, 1997b, Olsen et al. 2006) and 
in brain slice preparations (Grosshans et al. 2002a, 2002b). Like the biotin derivatives and 
BS3, the proteases are membrane-impermeant and inaccessible to the cytoplasmic proteins 
(Grosshans et al. 2002b), and can be used in physiological solutions and at physiological pH. 
However, unlike with biotinylation and BS3 cross-linking, the physiological temperature 
requirement for progression of the proteolytic cleavage has been a significant drawback in its 
utilization in quantitative analysis of surface expressed proteins since the trafficking of 
membrane proteins is not blocked during the entire incubation time (Boudreau and Wolf 
2005, Grosshans et al. 2002b). Hence, surface expression of proteins like KCC2 with a highly 
dynamic endocytotic-recycling trafficking rate (Lee H. H. et al. 2007, Rivera et al. 2004, 
Zhao et al. 2008) can be over-approximated leading to misinterpretations (Grosshans et al. 
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2002b, Study II). Importantly, several other membrane proteins important in 
neurotransmission have been shown to undergo a constitutive, dynamic endocytosis-
reinsertion cycles at basal conditions, including GABAAR (Kittler and Moss 2003, Porcher et 
al. 2011), AMPAR subunits glutamate receptors 2/3 (GluR2/3) (Malinow and Malenka 2002, 
Malinow et al. 2000), dopamine transporter (DAT) (Holton et al. 2005, Loder and Melikian 
2003) and GABA transporter (GAT) (Deken et al. 2003). Taking advantage of previous 
reports of utilization of homologous enzymatic proteins from species thriving at extreme 
temperatures  for  biotechnologically  relevant  themes  (e.g.,  see  Vosberg  1989  for  the  use  of  
DNA polymerase from Thermus aquaticus in  the  polymerase  chain  reaction  or  PCR),  we  
utilized a cold-adapted trypsin from cod fish (Jonsdottir et al. 2004) to address this issue and 
successfully quantified the absolute surface expression of both AMPAR subunit GluR4 and 
KCC2 at low temperatures when trafficking of membrane proteins is inhibited (Study II).  
Unlike GluR2 and GluR3 which have a shorter intracellular C-terminal chain 
and whose surface expression is dynamically regulated by a constitutive endocytotic-
recycling pathway, the surface pools of GluR1 and GluR4 are more stable and do not show a 
similar constitutive recycling under basal conditions which is thought to be because of 
differential interaction with binding partners for their longer carboxy tails of GluR1 and 4 
(Bredt and Nicoll 2003, Gomes A. R. et al. 2003, Greger and Esteban 2007, Groc and 
Choquet 2006, but see Ehlers 2000). Using the property of a reduced membrane recycling 
rate of GluR4, we showed that while quantification of surface expression of proteins like 
GluR4 is not compromised when the proteolysis is carried out at mammalian physiological 
temperatures, it can indeed be misleading for proteins like KCC2.    
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2.  Aims of the study 
  The  hypothesis  tested  in  this  study  was  whether  the  stability  of  total  and  
plasmalemmal KCC2 protein levels in the rat hippocampus is regulated by post-translational 
mechanism.  
The specific aims were as follows: 
1) To analyze the effects of a seizure episode on KCC2 function in neonatal rat 
hippocampus and the underlying mechanism. 
2) To design a reliable method for quantitative analysis of surface expressed proteins. 
3) To assess the stability of the total and surface expressed KCC2 protein levels and to 
understand the mechanism involved in the fast down-regulation of KCC2 function in 
pathophysiological states of excitotoxicity and hyperexcitability. 
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3.  Experimental procedures 
3.1 Preparation and maintenance of slices 
Hippocampal slices from P5-7 and P15-22 rats (Wistar) were used. The animals 
were anesthetized with halothane (Sigma), decapitated and the brains were removed and 
immersed in ice-cold sucrose-based cutting solution containing (in mM): 87 NaCl, 2.5 KCl, 
0.5 CaCl2, 25 NaHCO3, 1.25 NaH2PO4, 7 MgCl2, 50 sucrose and 25 D-glucose, equilibrated 
with 95% O2 and 5% CO2. 600 µm horizontal or 400 µm coronal acute brain slices were cut 
using a Vibratome 3000 (Vibratome). The slices were allowed to recover at 34?C in standard 
physiological solution containing the following (in mM): 124 NaCl, 3 KCl, 2 CaCl2, 25 
NaHCO3, 1.1 NaH2PO4, 2 MgSO4, and 10 D-glucose, equilibrated with 95% O2 and 5% CO2, 
pH 7.4 for 1 hour.  
 
3.2 Induction of neonatal seizures 
Seizures were induced in male P5-7 rat pups with a single intraperitoneal 
injection of kainate (2 mg/kg body weight; Tocris Bioscience). An identical volume of 100 µl 
saline was injected in control rats. Rats were injected in pairs, with a 1 hour interval between 
the littermates and a randomized order of saline and kainate injections. Behavioral seizures 
progressed from an initial stage of immobility, followed by bouts of scratching behavior, 
hyperactivity, ataxia, and isolated myoclonic jerks, into tonic or tonic-clonic seizures. 
Continuous behavioral monitoring was performed by video recording to define the onset of 
seizures (the initial stage of immobility). Slices containing the hippocampus were prepared 
after a 1 hour seizure period. Slices from saline-injected rats were prepared 1.5 hours after the 
injection. 
 
3.3 Induction of seizure-like activity in vitro 
Seizure-like activity was induced by a 10 minutes incubation of horizontal 
hippocampal slices (600µm) in 300 nM kainate in physiological solution (in mM): 124 NaCl, 
4  KCl,  1.3  CaCl2, 25 NaHCO3, 1.1 NaH2PO4, 1.3 MgSO4, and 10 D-glucose, equilibrated 
with 95% O2 and 5% CO2, pH 7.4 at the experimental temperature of 34°C. After 10 min, the 
slices were transferred to physiological solution with 1 µM TTX (Tocris Bioscience) added to 
block neuronal activity and 10 µM bumetanide to block NKCC1. In biochemical 
experiments, a 5 minutes kainate application followed by a 5 minutes washout with 
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physiological solution was repeated up to six times. Some slices were pre-exposed to 200 nM 
K252a for 30 min before exposure to kainate plus K252a. 
 
3.4 Western blot analysis  
Hippocampal slices or CA1 regions isolated from them were homogenized in 
RIPA buffer (150 mM NaCl, 1% Triton-X, 0.5% deoxycholic acid, 0.1% SDS and 50 mM 
Tris-Cl, pH 8.0) with a protease inhibitor mixture (Roche). Proteins were separated by SDS-
PAGE. Gel loading was performed in Laemmli buffer containing 80mM Tris-HCl, 2% SDS, 
10% glycerol, 5.3% ?-mercaptoethanol and 2% bromophenol blue. Proteins were then 
transferred onto nitrocellulose membranes (PerkinElmer) electrophoretically in transfer 
buffer containing 25 mM Tris, 192 mM glycine and 10% methanol, pH 8.3. Membranes were 
blocked in TBST/milk (20 mM Tris, 150 mM NaCl, 0.1% Tween-20 and 5% nonfat dry milk, 
pH 7.5) for 1 hour at room temperature. Incubation with the respective antiserum diluted in 
TBST/milk  was  performed  overnight  at  4?C  with  agitation.  The  primary  and  secondary  
antibodies used for quantitative analysis of the blots have been described in the respective 
original publications included in this thesis. After washing the blots in TBST to remove 
unbound primary and secondary antibodies, the immunoreactive signals were detected using 
an enhanced chemiluminescence kit (Pierce) and an LAS-3000 documentation system 
(Fujifilm). Quantification of the chemoluminescent signals was performed by Advanced 
Image Data Analysis imaging software (Raytest). All measurements were within the linear 
range of the sensitivity of the camera. After quantification, the representative images included 
in the figures were optimized for brightness and contrast using Paint Shop Pro X (Corel) and 
Microsoft Powerpoint. 
 
3.5 Surface biotinylation 
Test and control hippocampal slices were labeled with 100 µM biotin 
(Biotinamidohexanoyl-6-aminohexanoic acid N-hydroxysuccinimide ester; Sigma) in 
standard physiological solution on ice for 1 hour with continuous equilibration with 95% O2 
and 5% CO2. The reaction was quenched by washing the slices with 1 M glycine or 100 mM 
lysine in standard physiological solution for 10 minutes on ice. Hippocampal slices or 
isolated CA1 regions were homogenized and the biotinylated proteins were purified on 
immobilized  streptavidin  agarose  (Sigma)  and  eluted  in  SDS-PAGE  sample  buffer  at  75°C  
for  10  minutes.  The  eluent  from  the  streptavidin  column  (biotinylated  proteins)  and  the  
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supernatant (unlabeled internal proteins) were separated on SDS-PAGE and the immunoblot 
analysis was performed as described above.  
 
3.6 Trypsin cleavage of surface proteins 
Hippocampal slices (400 µm) were treated with cod trypsin (2 U/ml in standard 
physiological solution with continuous oxygenation) on ice for 1 hour. After a wash step (10 
minutes in standard physiological solution on ice), the hippocampal slices were homogenized 
and the immunoblot analysis for the proteins in the homogenate was performed as described 
above.  
Human embryonic (HEK) cells over-expressing the protein of interest were 
washed with ice cold phosphate buffered saline (PBS) on ice. The incubation with 2 U/ml cod 
trypsin was carried out on ice in PBS for 1 hour. The reaction was stopped by the addition of 
protease inhibitor cocktail (Roche). Cells were then homogenized in RIPA buffer and the 
immunoblot analysis was performed as described above.  
 
3.7 In vitro calpain cleavage assay 
Rat brain homogenate was diluted to about 1-2 mg/ml of protein in a final 
volume of 500 ?l (as assessed by a BioRad DC protein assay kit; BioRad). Rat calpain-2 (m-
calpain) (CalBiochem) was added at a concentration of 20 mg/ml in calpain assay buffer (100 
mM HEPES, 50 mM NaCl, 0.1% Triton-X, 20 mM CaCl2 and 20 mM dithiothreitol, pH 7.4). 
The cleavage reaction was stopped after 10, 20, or 30 minutes by adding 0.1 M EDTA and 
protease inhibitors (Complete Mini EDTA free protease inhibitor mixture; Roche). In some 
experiments, calpain-2 was pre-incubated with 100 mM MDL 28170 for 5 minutes. 
 
3.8 Ionomycin assay of calpain activation 
To  directly  raise  [Ca2+]i, coronal rat brain slices bathed in standard 
physiological solution were treated with 50 ?M ionomycin (Ascent), a Ca2+ ionophore, at 
34°C for 4 hours. Slices treated with 30 ?M MDL 28170 in addition to ionomycin were pre-
incubated with MDL 28170 for 30 min. 
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4.  Results and Inferences 
4.1 Study I 
The results and inferences obtained from data collected during Study I are as follows: 
1) In spite of a low protein expression of KCC2 in P5-7 rats which have depolarizing 
GABAergic responses, a single seizure event induced by kainic acid that has been 
used as a model for temporal lobe epilepsy (cf. Ben-Ari and Cossart 2000) culminated 
into an increased surface expression and chloride extrusion function of KCC2 both in 
vivo and in vitro. This was observed as a shift in ECl- to hyperpolarizied levels, similar 
to  what  is  seen  in  hippocampal  neurons  from mature  rats.  This  indicates  that  KCC2 
has a low plasma membrane expression under basal conditions (see Study II) and that 
the total protein levels in developing rats are sufficiently high to set off 
hyperpolarizing GABAergic responses and a somato-dendritic Cl- gradient 
comparable to adults. Hence, blocking of endocytosis of KCC2 which has a fast 
endocytosis-recycling rate (cf. Lee H. H. et al. 2007, Study II) by dynamin inhibitory 
peptide (DIP) caused a similar effect on the chloride driving force of GABAAR.     
2) Since the above shift in depolarizing to hyperpolarizing GABAergic responses were 
observed in absence of any increase in KCC2 expression but rather depended on an 
increased surface expression, it implies that post-translational regulation of KCC2 
may  also  play  a  role  in  the  developmental  shift  in  the  GABA  switch.  However,  the  
part played by a developmental increase in KCC2 protein levels cannot be overlooked 
since the protein levels in P16 rat hippocampus are not similar to those in P5-7 rats, 
although an increase in spine density during development might also be reflected in 
the amount of KCC2. On the other hand, translational up-regulation of KCC2 can 
consolidate the effects of an increased KCC2 plasma membrane expression/function 
by post-translational mechanisms during development in an activity-dependent 
manner. 
3) Interestingly, analogous to the signaling mediated by neurotrophic factors implicated 
in the developmental increase of KCC2 protein expression (see section 1.3.2), the fast 
post-translational increase in the KCC2 surface expression and function could be 
blocked by the kinase inhibitor K252a and was dependent on BDNF-TrkB signaling 
(unpublished data). 
4) Although Na+-K+ ATPase  ?2  subunit  has  a  predominantly  glial  expression,  it  is  
known to be expressed in embryonic neurons (cf. Moseley et al. 2003) as well as in 
young hippocampal neurons (cf. Cameron et al. 1994) and might function as a 
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thermodynamic energy source for the KCC2-mediated cotransport in the neonatal 
brain (see section 1.2.2.1). The increased KCC2 plasma membrane expression and Cl- 
extrusion function, paralleled by an increased surface expression of Na+-K+ ATPase 
?2 subunit might contribute to an intrinsic anti-epileptogenic mechanism responsible 
for a high resistance of immature neuronal circuits to seizures by increasing 
GABAergic hyperpolarizing inhibition. In neonatal brain, KCC2a and KCC2b show 
similar expression patterns and levels, largely co-localize, form heteromers and have 
comparable cotransport activity (cf. Uvarov et al. 2007, 2009). Not surprisingly then, 
surface expression of both KCC2 isoforms in neonatal rat CA1 neurons was affected 
in a similar manner after the single seizure episode.  
 
4.2 Study II 
The results and inferences obtained from data collected during Study II are as follows: 
1) The problems encountered during quantitative analysis of plasma membrane 
expression of proteins by established methods like sub-cellular fractionation, biotin-
labeling and BS3-mediated cross-linking are highly suggestive of using at least two 
different biochemical procedures for the same (see section 1.7). Hence, an existing 
protocol of molecular shaving of surface expressed proteins to quantitate their 
expression was modified to be operational at low temperatures so that it could be 
conveniently used for membrane proteins that have a short plasmalemmal half life and 
a high recycling rate. Using a mammalian protease, we showed that molecular 
shaving of surface expressed proteins at mammalian physiological temperatures can 
lead to erroneous results for plasmalemmal proteins like KCC2 which have a fast 
recycling rate. On the other hand, surface analysis of plasmalemmal proteins like 
AMPAR subunit GluR4 that have stable surface expression can be carried out at 
mammalian physiological temperatures. 
2) We established the cod-trypsin catalyzed proteolysis for quantitative analysis of 
surface expression of proteins at low temperatures. As a proof of principle, we studied 
the kinetics of cod-trypsin-mediated cleavage of surface expressed proteins for both 
KCC2 and GluR4. Further, we demonstrated that the technique can be used for both 
qualitative (using a mutant of GluR4, R507K that is incapable of being targeted to the 
membrane (cf. Coleman et al. 2009)) and quantitative (plasma membrane expression 
of KCC2 in control slices and slices treated with a PKC activator (cf. Lee H. H. et al. 
2007)) analysis of surface expressed proteins.  
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3) Finally, we showed that expression of KCC2 in the plasma membrane is indeed very 
low (15-20% of total KCC2 protein) and that it has a fast recycling rate under basal 
conditions that can be regulated by post-translational mechanisms (cf. Lee H. H. et al. 
2007, Study I) to eventually alter the surface expression and the function of the 
cotransporter. 
           
4.3 Study III 
The results and inferences obtained from data collected during Study III are as follows: 
1) The major surprising conclusion from these data was that under basal conditions 
KCC2 protein exhibits a high stability and a low turn-over rate. Previous studies 
indicated that KCC2 protein has a very high turn-over rate (cf. Rivera et al. 2004, Lee 
H. H. et al. 2010). However, our experimental data based upon selective blockade of 
both protein synthesis and protein degradation via the lysosomal pathway supported a 
stable KCC2 protein expression in P15-21 rat hippocampus. Interestingly, Zhao et al. 
(2008) also showed that even when the stability of plasmalemmal KCC2 was low 
under basal conditions, the endocytosed proteins was not degraded but rather recycled 
back to the membrane. 
2) KCC2  harbors  PEST  sequences  that  have  been  implicated  in  constitutive  as  well  as  
conditional protein degradation (see section 1.4.4). Indeed, while we showed that 
KCC2 protein and function levels are quite stable under basal conditions, we also 
demonstrate that KCC2 protein and function can be down-regulated by proteases-
mediated cleavage/degradation. Hence, we demonstrated that KCC2 can be cleaved 
by calpain both in vitro and under pathophysiological conditions of excitotoxicity as 
well as epileptiform activity. The latent PEST domains in KCC2 might be speculated 
to be activated for regulated proteolysis by phosphorylation/dephosphorylation 
mechanisms (cf. Lee H. H. et al. 2010, 2011).   
3) Establishment of KCC2 as a target of calpain-catalyzed cleavage is particularly 
interesting as KCC2 function and hence GABAergic signaling can consequently be 
altered by calpain. Along similar lines, although we did not show this, structural 
aspects of KCC2 in both GABAergic and glutamatergic synaptic signaling might be 
expected to experience amendments in a calpain-dependent manner.       
 
In summary, the studies included in this thesis underline the importance of post-translational 
regulation of KCC2 function mediated by changes in the plasmalemmal expression levels as 
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well as protein proteolysis in the rat hippocampus. In addition, an improved method for 
quantitative analysis of surface expressed proteins at low temperatures when protein 
trafficking is halted, was also designed. Future studies would be targeted at the cellular 
mechanisms  responsible  for  changes  in  the  surface  pool  of  KCC2  and  to  develop  a  
methodology to quantify the insertion of highly mobile membrane proteins like KCC2 into 
the plasma membrane. 
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